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Abbreviations
AC anterior chamber
AC IOL anterior chamber intraocular lens 
ALT argon laser trabeculoplasty
BCVA best corrected visual acuity
CME cystoid macular edema
ECCE extracapsular cataract extraction 
EG exfoliation glaucoma
F female
ICCE intracapsular cataract extraction
IOL intraocular lens
IOP intraocular pressure
LSL laser suture lysis
M male
OAG open-angle glaucoma
PMMA polymethylmethacrylate 
POAG primary open-angle glaucoma
SD standard deviation
VA visual acuity
VF visual fi eld
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Abstract
During this study, trabeculectomy has been the operation of choice for improving aqueous 
outfl ow to decrease intraocular pressure (IOP) in primary open-angle glaucoma (POAG) 
and exfoliation glaucoma (EG) at the Helsinki University Eye Hospital. This retrospective 
study was designed to examine long-term IOP control, further progression of visual fi eld 
(VF) defects and visual impairment, and need for cataract surgery after trabeculectomy, and 
to evaluate possible factors related to these outcome measures in POAG and EG.
One hundred thirty-eight eyes of 138 consecutive patients over 40 years of age with POAG 
or EG undergoing trabeculectomies without the use of antimetabolites were studied. All 
surgeries were performed by one surgeon (I.L.) between November 1994 and August 1996. 
The mean age of the patients at trabeculectomy was 70.1 years. Of the 138 patients, 83 
(60%) were females; 83 eyes (60%) had EG. Mean follow-up was 3.5 years (range 2-5 
years). All patients were Caucasian.
Before trabeculectomy, the mean IOP was 24.6 (SD 5.8) mmHg in POAG and 28.0 (SD 
11.2) mmHg in EG (p=0.044). At the last examination, the mean IOP in POAG was 16.6 
(SD 4.2) mmHg and in EG 17.1 (SD 6.2) mmHg (p=0.95). Success rates for IOP control, 
without medication (complete success) or with one topical medication (qualifi ed success) 
in the whole series, were 82% at 1 year, 70% at 2 years, 64% at 3 years, and 52% at 4 years. 
Rates for complete success were 63%, 54%, 45%, and 40%, respectively. Complete suc-
cess was signifi cantly more common in POAG than in EG (p=0.04), but when complete 
and qualifi ed success were combined, the difference between POAG and EG became non-
signifi cant.
In EG, the patients were signifi cantly older (p=0.03) and had higher preoperative IOP 
(p=0.044), and postoperative hyphema was more common (p=0.011), but none of these 
factors was an independent signifi cant predictor of failure. Insuffi cient fi ltration (antiglau-
comatous medication) at the end of the fi rst postoperative month predicted long-term fail-
ure (p=0.0084).
 Of the 83 eyes with comparable pre- and postoperative VF, the preoperative VF defect was 
considered severe in 33 eyes (40%). In 34 cases (41%), glaucomatous fi eld defects pro-
gressed. Severe preoperative VF defect (p=0.0047), preoperative oral glaucoma medication 
(p=0.047), smaller initial IOP reduction from preoperative to 1-month follow-up (10.9 vs. 
15.4 mmHg) (p=0.023), and smaller IOP reduction from preoperative to last postoperative 
examination (9.2 vs. 12.8 mmHg) (p=0.036) were signifi cantly related to VF progression. 
10 Abstract
But the mean IOP at the last examination, 16.3 (SD 3.8) mmHg in eyes without progres-
sion and 17.6 (SD 7.4) mmHg in eyes with progression (p=0.58), or the mean number of 
topical antiglaucoma medicines did not differ. The high standard deviation of the mean last 
postoperative IOP indicates, however, that during follow-up, the IOP had been too high in 
some eyes that progressed. The prevalence of glaucoma-related low vision had increased 
from 6% to 7% and that of blindness from 4% to 10% in the operated eye.
During the follow-up of 2 to 5 years, 48 of the 138 eyes (35%) underwent a cataract opera-
tion performed 5.1 to 58.1 months (median 14.4 months) after trabeculectomy. Patients 
undergoing cataract surgery during the follow-up were signifi cantly older (73.9 (SD 9.4) 
years) at the time of trabeculectomy than those without the operation (68.1 (SD 9.8) years) 
(p=0.001), and had worse visual acuity before trabeculectomy. At the last examination, the 
mean IOP 17.3 (SD 6.4) mmHg was not signifi cantly higher than before cataract surgery 
(p=0.35), but the mean number of topical antiglaucoma medicines had increased signifi -
cantly to 1.3 (SD 1.1) (p=0.0007). In 41% of the eyes, use of topical antiglaucoma medi-
cines had increased after cataract surgery, although in an eye with good IOP control (com-
plete success), a cataract operation improved the chances that the eye remained a complete 
success.
These results emphasize the importance of early postoperative control and therapy after 
trabeculectomy and the regular long-term follow-up of glaucoma patients including VF 
examinations also in cases with initially successful surgery. Earlier surgery might have 
improved the outcome. In eyes with good IOP control following trabeculectomy, cataract 
surgery may not worsen outcome. 
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1. Introduction
After critical appraisal of the glaucoma literature covering the years 1975 to 2002, the Finn-
ish Glaucoma Guideline Team found ‘strong research-based evidence’ (Level A) for the 
statement that surgical treatment reduces intraocular pressure (IOP) more than does medi-
cal or laser treatment, but gave no strict guidelines based on scientifi c evidence concerning 
the type of surgery (Tuulonen et al. 2003).
Since the late 1960’s, trabeculectomy has been the operation of choice for improving aque-
ous outfl ow in glaucomatous eyes (Cairns 1968, Watson & Grierson 1981), and trabeculec-
tomy is still regarded as the gold standard to which the newer operations are compared. The 
long-term successful control of IOP in eyes that have undergone primary trabeculectomy 
has ranged from 48 to 98%, depending on follow-up time and the criteria used to defi ne 
successful outcome (Jerndal & Lundström 1979, D’Ermo et al. 1979, Mills 1981, Watson 
& Grierson 1981, Lamping et al. 1986, Akafo et al. 1992, Vesti 1993, Nouri-Mahdavi et al. 
1995, Vesti & Raitta 1997, Jacobi et al. 1999). In most studies, complete success in terms of 
IOP has been described as an IOP of 21 mmHg or less, without medication. In 1993, Vesti 
reported a success rate of 74% without glaucoma medication after a mean follow-up period 
of 3 years in a selected group of Finnish patients. In her study, eyes with long-term miotic 
therapy and advanced exfoliation glaucoma (EG) were underrepresented.
Glaucoma is one of the main causes of visual impairment in older age groups, in patients 
aged over 65 years in Finland, it causes 10% of visual impairment (Ojamo 2003). The ben-
efi cial effect of reducing IOP by surgery, laser or medical treatment on visual fi elds (VF) 
has been shown in several studies (Jay & Murray 1988, Vogel et al. 1990, Mao et al. 1991, 
Migdal et al.1994, Suzuki et al. 1999, The AGIS Investigators 2000, Leske et al. 2003), 
but in some eyes the defects progress despite aggressive treatment (Watson et al. 1990, 
Brubaker 1996). Questions regarding risk indicators for VF defect progression and visual 
loss and the effect of trabeculectomy on these events in open-angle glaucoma (OAG) have 
been diffi cult to answer. Progression rates of VF defects after trabeculectomy have varied 
considerably, partly due to different criteria of VF loss, partly due to different length of fol-
low-up; the probability of progressive fi eld loss at 5 years’ follow-up has been reported in 
27% (Parc et al. 2001), and at 11 to 15 years in 46% (Molteno et al. 1999).
In order to further improve and optimise glaucoma surgery success, the adjunctive use of 
antimetabolites (The Fluorouracil Filtering Surgery Study Group 1996, Bindlish et al. 2002), 
drainage device implantation (Wilson et al. 2000), and nonpenetrating glaucoma surgery 
techniques (Ambresin et al. 2002, Lüke et al. 2002, Carassa et al. 2003) have been inves-
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tigated. One reason for the development of nonpenetrating surgery is the fairly common 
occurrence of postoperative complications after trabeculectomy, although effects of com-
plications on the long-term outcome have rarely been reported. Further, the location of the 
trephined tissue block in the anterior chamber (AC) angle may infl uence the rate of postop-
erative complications and the long-term success of IOP control after trabeculectomy.
Numerous studies show that trabeculectomy expedites cataract formation (D’Ermo et al. 
1979, Mills 1981, Watson & Grierson 1981, Törnqvist & Drolsum 1991, Akafo et al. 1992, 
Nouri-Mahdavi et al. 1995, Vesti & Raitta 1997, Popovic & Sjöstrand 1999, The AGIS In-
vestigators 2001). Age, EG, postoperative hypotony, marked infl ammation, and shallow or 
fl at AC after trabeculectomy have been considered risk indicators for cataract progression 
(Mills 1981, Vesti 1993, The AGIS Investigators 2001). The effect of cataract surgery on 
IOP control in eyes that have undergone trabeculectomy varies because of patient selection 
and type of cataract surgery. 
In the elderly Finnish population (70 years or older), the prevalence of exfoliation syn-
drome is more than 20% (Krause 1973, Peräsalo & Raitta 1992, Hirvelä et al. 1995), more 
than half the patients with exfoliation syndrome have glaucoma (Tarkkanen 1962), and 
about half the patients with OAG have exfoliation (Lindberg 1917, Hirvelä et al. 1995). 
Comparison of the outcome of trabeculectomy between eyes with primary open-angle glau-
coma (POAG) and with EG therefore, warrants special attention.
This study was designed to evaluate the outcome of trabeculectomy retrospectively in a 
series of consecutive cases of POAG and EG that had undergone primary surgery by a 
conventional technique without antimetabolites. Conventional trabeculectomy was the 
technique mainly used for refractory glaucoma at the Helsinki University Eye Hospital 
at the beginning of this study. Due to the well-known complications of trabeculectomy 
with antimetabolites (Kitazawa et al. 1991, Borisuth et al. 1999), use of these agents was 
limited to the high-risk cases, and nonpenetrating surgeries had not yet been introduced 
in this hospital. The aim was to obtain information on long-term IOP control, on further 
progression of VF defects and visual impairment, and on the need for cataract surgery af-
ter trabeculectomy, and to evaluate possible factors related to these outcome measures in 
POAG and EG.
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2. Review of the literature
2.1 Indications and technique of trabeculectomy
In the literature, indications for glaucoma surgery have generally been failure of the maxi-
mal tolerated medication to control IOP or disease progression or both. 
In 1961, Sugar described a case of ‘experimental trabeculectomy’, but for clinical use, trab-
eculectomy was accepted after the description of the technique by Cairns (1968). In the origi-
nal technique, guarded by a half-thickness scleral fl ap, the intention was to excise a short 
length of the canal of Schlemm, with its trabecular adnexae anterior to the line of the scleral 
spur, leaving two cut ends opening directly into aqueous humor, with no trabecular tissue 
remaining as a barrier at that point. Originally, the aim was to relieve trabecular obstruction 
without intentionally creating external drainage. However, in a series of 80 cases, Cairns 
(1972) reported 67.5% controlled with a drainage bleb. Nowadays, this partial-thickness fi l-
tration operation is considered to reduce IOP via the establishment of a limbal fi stula through 
which aqueous humor drains into the subconjunctival space, establishing a fi ltering bleb. 
Since the original description of trabeculectomy, numerous modifi cations have been pro-
posed, and some of these have been investigated in intervention studies, these involving 
more posterior location of the trabeculectomy (Watson 1970), site of surgery (Vesti & Raitta 
1992, Sanders et al. 1993), limbus- versus fornix-based conjunctival fl ap (Shuster et al. 1984, 
Traverso et al. 1987), partial versus total tenonectomy (Miller et al. 1991), scleral fl ap size 
(Starita et al. 1984) and shape (rectangular versus triangular) (Kimbrough et al. 1982), high 
initial outfl ow vs standard technique (Batterbury & Wishart 1993), use of a trephine for dis-
section of trabecular meshwork (Fronimopoulos et al.1970), laser suture lysis to augment 
fi ltration when necessary (Hoskins & Migliazzo 1984, Savage & Simmons 1986), releasable 
sutures (Kolker et al. 1993, Raina & Tuli 1998), needling versus medical treatment in encap-
sulated blebs (Costa et al. 1997), scleral tunnel incision (Vuori & Viitanen 2001), and use of 
antimetabolites (5-fl uorouracil and mitomycin) to inhibit postoperative fi brosis (The Fluor-
ouracil Filtering Surgery Study Group 1989, The Fluorouracil Filtering Surgery Study Group 
1996, Kitazawa et al. 1991, Bindlish et al. 2002). Postoperative steroids have been shown to 
be benefi cial and limit the wound-healing process (Roth et al. 1991, Araujo et al. 1995). 
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2.2 Outcome of trabeculectomy
2.2.1 Defi nition of outcome
The aim of glaucoma surgery is to retard or halt glaucomatous VF loss. Interpretation of 
visual fi elds and detection of progression is, however, diffi cult (Werner et al. 1988, Katz 
et al. 1999, Salim et al. 2001). IOP has thus usually served as a measure of success. Since 
the presentation of the fi rst trabeculectomy series by Cairns in 1968, the most common 
criterion for surgical success has been IOP <21 mmHg or ≤21 mmHg. In some studies, a 
proportionate criterion as a reduction in IOP of at least 20% or 33% from the presurgical 
level has served as an additional criterion for success (Nouri-Mahdavi et al. 1995, Chen et 
al. 1997, Edmunds et al. 2001), and some studies have used progression of visual fi eld or 
optic disc defects or both as defi nition of failure (Törnqvist & Drolsum 1991). Success has 
been further defi ned as complete or qualifi ed depending on whether the IOP was controlled 
without or with postoperative antiglaucoma medication, respectively (Mietz et al. 1999).
2.2.2 Outcome of trabeculectomy in open-angle glaucoma
In the literature, the outcome measures for trabeculectomy and the diagnoses of eyes oper-
ated on vary, making comparisons diffi cult. The defi nition ‘long-term’ has been used for 
follow-up times beginning from 1 year. In the early reports on trabeculectomy, the success 
rate in POAG ranged from 65% to 83% without medication (Table 1) and from 77% to 98% 
with the use of additional medical therapy or surgery or both after 1 to 2 years’ follow-up 
(D’Ermo et al. 1979, Watson & Grierson 1981). Similar short-term IOP results (1-year fol-
low-up) were obtained more recently in a large national survey in the United Kingdom car-
ried out in 1996; the fi nal IOP of less than 21 mmHg was achieved in 84% without medica-
tion and in 92% with antiglaucoma medication (Edmunds et al. 2001), and in a study with 
POAG patients over 46 years old the success rate was 79% at 1 year and 72% at 2 years 
without medication (Briggs & Jay 1999). Some studies have, however, reported less favour-
able results. Jerndal and Lundström (1977) reported success without medication in 58% of 
eyes after 1.5 to 3 years, Mietz et al. (1999) in 53% in eyes with stable VF and optic disc in 
6 to 62 months, and Diestelhorst et al. (1999) in 48% after mean follow-up of 16.3 months.
In the early studies, the percentage of well-controlled eyes was believed to be substantially 
constant up to 5 years (D’Ermo et al. 1979). Later, the success rate has appeared to decrease 
with time (Popovic & Sjöstrand 1991, Briggs & Jay 1999). A decrease in success from 
48% to 40% at 3 and 5 years, respectively, occurred when success was defi ned as IOP ≤20 
mmHg and a reduction in IOP of at least 20% from the presurgical level (Nouri-Mahdavi 
et al. 1995).
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Table 1. Success rates without medication in studies of primary open-angle glaucoma (POAG) 
eyes, with intraocular pressure (IOP) level of 21 mmHg as the limit for surgical success
              Follow-up
Authors, Year 1–2 years 3–4 years 5 years 7years
D’Ermo et al. 1979 65%
Jerndal & Lundstöm 1977* 58%
Jerndal & Lundstöm 1980*   57%
Watson & Grierson 1981 83%
Kidd & O’Connor 1985   75%
Akafo et al. 1992*    67%
Vesti 1993  77%
Downes et al.1994 67%
Mietz et al. 1999 53%
Briggs & Jay 1999 72% 66% 
Diestelhorst et al. 1999 48%
*open-angle glaucoma
2.2.3 Comparison of success in primary open-angle glaucoma and exfoliation 
glaucoma
Some studies comparing the results of trabeculectomy in POAG and EG are summarized 
in Table 2. Mills (1981) found a lower success rate (64%) in a small number of exfoliation 
eyes (n=14) than in POAG (73%) without medication. In contrast, better control without 
further therapy in EG than in POAG at 5 years has also been reported (Törnqvist & Drol-
sum 1991). In the latter study, however, EG eyes were operated on at an earlier stage. Most 
of the previous studies seem to show no signifi cant difference in the outcome of trabeculec-
tomy between POAG and EG (Mietz et al. 1999, Popovic & Sjöstrand 1999, Serguhn & 
Spiegel 1999, Edmunds et al. 2001). The proportionate reduction in IOP can, however, be 
signifi cantly higher in EG because of initially higher IOP in EG (Edmunds et al. 2001).
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Table 2. Success rates of intraocular pressure (IOP) control after trabeculectomy in eyes with 
primary open-angle glaucoma (POAG) and exfoliation glaucoma (EG)
Authors No. of eyes Success Success  Follow-up 
year POAG/EG criteria without medication months
   POAG (%) EG (%)
Mills 1981 220/14 <21 mmHg 73% 64% not reported
Törnqvist & 84/160 without 56% 77% 24
Drolsum 56/107 defect 43% 64% 60
1991  progression*
Mietz et al. 1999 209/117 ≤21 mmHg* 53% 51% 6–62
Popovic & 42/53 without 64% 58% 46
Sjöstrand 1999  medication
Serguhn & 23/21 <21 mmHg+ 78%** 81%** 12
Spiegel 17/21 ≥20% 71%** 86%** 24
1999  decrease in IOP**
Edmunds 1105/64 ≥33% 66% 70% 12
et al. 2001  decrease in IOP
VF = visual fi eld
* VF and optic disc required to be stable
** With or without medication
2.2.4 Preoperative factors related to poor postoperative IOP control
Various preoperative factors related to poor long-term IOP control have been suggested, 
such as the type and/or length of preoperative medication (Watson & Grierson 1981, Sher-
wood et al. 1989, Lavin et al. 1990, Broadway et al. 1994, Liesegang 1998), preoperative 
argon laser trabeculoplasty (ALT) (Schwartz et al. 1999), younger age, higher preoperative 
IOP, and diabetes (The AGIS Investigators 2002). Further, in POAG, early trabeculectomy 
has been reported to be more successful than delayed trabeculectomy (Lavin et al. 1990, 
Broadway et al. 1994).
2.2.5 Early postoperative complications
The occurrence of early postoperative complications in previous studies is summarized 
in Table 3. Some authors report no correlation between surgical complications and the 
long-term results of the operation (D’Ermo et al. 1979, Lavin et al. 1990, Watson et al. 
1990). However, in the Advanced Glaucoma Intervention Study (The AGIS Investigators 
2002), failure of trabeculectomy was associated with any postoperative complication; of 
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the individual postoperative complications, elevated IOP and marked infl ammation were 
statistically signifi cant, but the effects of other specifi c complications were not reported 
separately. 
Table 3. Early postoperative complications of trabeculectomy
Authors No. of eyes Hyphema Shallow AC* Flat AC* Choroidal 
year (patients)    detachment
D’Ermo et al. 1979 90(75) 9%  4% 4% 
Mills 1981 435(349) 7% 9% 4% 5%
Watson & Grierson 1981 424(268) 15% 13% 3%
Watson et al. 1990 239(177)  21% 3%
Törnqvist & 277(239) 17%  16%
Drolsum 1991
Downes et al. 1994 203(203) 24% 10% 2% 
Popovic 1995 60(60) 25% 13% 3% 23%
Molteno et al. 1999 289(193) 9% 7%  11%
Picht et al. 2001 113(113) 5% 8%  19%
The AGIS 509 11% 16% 9% 8%
Investigators 2002
Jampel et al. 2005 465(300) 10% 13% shallow or fl at 11% 
AC = anterior chamber
* defi nitions of shallow and fl at AC vary
Low IOP (<17 mmHg) on the fi rst postoperative day has been found to be an accurate pre-
dictor of a successful outcome (Downes et al. 1994). Results of the effect of early hypotony 
on the fi nal outcome have been controversial, ranging from no effect of IOP ≤5 mmHg 
(Popovic 1995) to a statistically signifi cant correlation between the lowest IOP in the early 
postoperative period and the 6-month and 12-month IOP (Schwenn et al. 2001) or to a 
greater chance of having higher fi nal IOP in eyes with IOP <8 mmHg for more than 2 weeks 
in the immediate postoperative period (Migdal & Hitchings 1988).
The effect of laser suture lysis (LSL) is also controversial. Unexpectedly, the fi nal mean 
IOP and the mean number of postoperative antiglaucoma medications have not differed 
signifi cantly between the LSL and the non-LSL groups (Asamoto et al. 1995, Macken et al. 
1996). It thus seems that LSL may not alter the fi brosis process of the fi ltering bleb. 
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2.2.6 Location of trephined block and its effect on complications and 
long-term success
The location of trabeculectomy in the anterior chamber angle may infl uence the incidence 
of postoperative complications and the fi nal success rate. In the anterior approach, a seg-
ment of the trabecular meshwork and the canal of Schlemm anterior of the scleral spur is 
removed (Cairns 1968), while in the more posterior approach, a segment of the scleral spur 
and the anterior longitudinal ciliary muscle is also dissected (Watson 1970). On comparing 
the complications of trabeculectomy by the anterior (115 eyes) and the posterior  (101 eyes) 
approach, Watson and Grierson (1981) found that the average fall in IOP and progression 
of  cataracts were signifi cantly greater with the anterior approach, whereas hyphemas were 
signifi cantly more common after the posterior approach. No statistically signifi cant differ-
ence occurred in incidence of shallow anterior chambers.
Histological surveys of trabeculectomies have revealed no correlation between the anatom-
ical location of the trephination (Duzanec & Kriegelstein 1981), or dissected block, (Taylor 
1976, Konstas & Jay 1992) and postoperative success. The occurrence of postoperative 
complications has, however, varied. Taylor (1976) found no difference in the development 
of a postoperative fl at anterior chamber or hyphema, Duzanec and Kriegelstein (1981) 
found that displacement of the trephination toward the sclera caused more postoperative 
choroidal detachments, and Konstas and Jay (1992) observed that the rate of hyphemas was 
signifi cantly greater in eyes with posterior trabeculectomy fi stulas.
2.2.7 Progression of visual fi eld defects
VF deterioration may occur over the years despite effective IOP-lowering therapy (Kidd & 
O’Connor 1985, Watson et al. 1990, Rosetti et al. 1993, Brubaker 1996). In previous stud-
ies, progression rates of VF defects have varied considerably, partly due to different crite-
ria of VF loss, partly due to different length of follow-up. The probability of progressive 
fi eld loss at 4-5 years’ follow-up has been reported in 18 to 27% (Kidd & O’Connor 1985, 
O’Brien et al. 1991, Parc et al. 2001), at 7 to 10 years in 27 to 76% (Hart & Becker 1982, 
Mikelberg et al. 1986, Chauhan & Drance 1992, Smith et al. 1996, Rasker et al. 2000, The 
AGIS Investigators 2002) and at 11 to 15 years in 46 to 68% (Molteno et al. 1999, Kwon et 
al. 2001). In trabeculectomy follow-ups based on survival methods, probability of progres-
sive fi eld loss at 5 years’ follow-up has been reported in 27% (Parc et al. 2001), and at 11 to 
15 years in 46% (Molteno et al. 1999). 
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2.2.8 Effect of IOP on progression of visual fi eld defects
The benefi cial effect of a lower IOP on VF progression has recently been documented in 
OAG in several randomised prospective studies. In the Advanced Glaucoma Intervention 
Study (The AGIS Investigators 2000), eyes with an average IOP greater than 17.5 mmHg 
over the fi rst three 6-month follow-up visits had more VF progression than eyes with IOP less 
than 14 mmHg. In the associative analysis, in eyes with IOP less than 18 mmHg over the fi rst 
6 follow-up years, mean changes from baseline in VF defect score were close to zero during 
6 or more years of follow-up. Even in this group, although mean IOP over the fi rst 6 years of 
follow-up was 12.3 mmHg, about 14% of eyes experienced considerable fi eld loss at 5 to 7 
years despite having IOP less than 18 mmHg at all study visits. On the other hand, 18% in the 
same group showed VF improvements at 7 years. Larger IOP fl uctuation (standard deviation 
of the IOP at all visits after the initial surgery) has also been associated with VF defect pro-
gression in eyes both with and without a history of cataract extraction in the Advanced Glau-
coma Intervention Study (Nouri-Mahdavi et al. 2004). In the Collaborative Initial Glaucoma 
Treatment Study (CIGTS) (Lichter et al. 2001), minimal change in VF score was observed 
when aggressive treatment, either medical or surgical, was aimed at substantial reduction in 
IOP from baseline. Average IOP was, over the course of follow-up, 17 to 18 mmHg in the 
medicine group and 14 to 15 mmHg in the trabeculectomy group. The Early Manifest Glau-
coma Trial (EMGT) (Leske et al. 2003) of early glaucoma showed that the progression risk 
decreased, with each mmHg of IOP reduction from baseline, by about 10%.
Several studies have tried to discover the level of a safe IOP. Mao et al. (1991) observed 
that in POAG and early glaucomatous damage, all the eyes with mean IOP higher than 21 
mmHg during the follow-up period of 4 to 11 years had progressive glaucomatous changes, 
and conversely, eyes with mean IOP less than 17 mmHg remained stable, and Migdal et 
al. (1994) found no signifi cant deterioration of VF in their trabeculectomy-treated group 
in which mean IOP at 5 years was 14.1 mmHg. Popovic and Sjöstrand (1999) reported a 
similar mean IOP (16.6 and 16.2 mmHg, respectively) and mean percentage of IOP reduc-
tion (39.5 and 41.7%, respectively) in eyes with unchanged/improved vs. deteriorated VF 
after trabeculectomy. 
The progression rate in eyes treated with medical therapy or fi ltration surgery seems to be 
the same if the IOP outcome is similar (Stewart et al. 1996). Greater IOP reduction and bet-
ter preservation of VF after surgical therapy have been reported (Jay & Murray 1988, Jay & 
Allan 1989, Migdal et al. 1994). In the CIGTS (Lichter et al. 2001), a clinically signifi cant 
VF loss at some point during 5 years’ follow-up was observed in 10.7% of medically and 
13.5% of surgically treated patients, but after 5 years’ follow-up, VF outcome was about the 
same in eyes having aggressive medical and in eyes with initial surgical therapy, although 
the IOP during the follow-up was 4 to 3 mmHg lower in the latter group. 
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2.2.9 Effect of other characteristics on progression of visual fi eld defects
Several characteristics other than IOP indicate a greater potential for defect progression. 
In most studies, older age seems to be a risk factor (Mao et al. 1991, Stewart et al. 2000, 
Lichter et al. 2001, Leske et al. 2003, Jonas et al. 2004), and some have found baseline VF 
score (Lichter et al. 2001, Leske et al. 2003), or higher baseline IOP and exfoliation (Leske 
et al. 2003) also as risk factors for VF progression. Other possible risk factors presented are 
a larger cup-to-disk ratio, greater number of medications, and worse visual acuity (Stewart 
et al. 2000), or nonwhite race, diabetes, and time of study (Lichter et al. 2001), or bilateral 
disease, and frequent disc haemorrhages during follow-up (Leske et al. 2003), or small 
neuroretinal rim area and large beta zone of parapapillary atrophy (Jonas et al. 2004). In 
contrast, Mao et al. (1991) found that neither initial optic nerve appearance, initial VF fi nd-
ings, number of medicines, medical history, gender, nor race were signifi cantly associated 
with stability or progression of glaucoma, but patients who remained stable were slightly 
younger. 
Findings on the infl uence of initial VF status on rate of progression are contradictory. No 
signifi cant correlation between the stage of glaucoma (i.e., starting fi eld score) and sub-
sequent change in fi eld score has been reported (Migdal et al. 1994, Rasker et al. 2000, 
Kwon et al. 2001), but Grant and Burke (1982) reported that eyes with more damage at 
presentation are more likely to go blind. Baseline VF was shown to be more damaged in 
eyes with progressing VF defects in high-pass resolution perimetry (Martínez-Belló et al. 
2000). It has also been evident that optic disc damage in eyes with advanced glaucomatous 
optic disc changes is more likely to progress despite IOP-lowering treatment, independent 
of IOP level (Tezel et al. 2001). In contrast, some studies have found VF with less baseline 
defect to be at increased risk for VF defect progression (O’Brien et al. 1991, The AGIS 
Investigators 2002). 
2.2.10 Development of low vision and blindness
Glaucoma-related visual impairment is one of the main causes of visual impairment in 
elderly people. In the Finnish Register of Visual Impairment it comes second (10%) after 
age-related macular degeneration (58%) in people aged 65 years and older (Ojamo 2003). 
Various studies’ prevalences of glaucoma-related visual impairment and blindness are diffi -
cult to compare, because the defi nition of blindness varies, and some studies do not separate 
glaucoma-related blindness from blindness due to other causes. Kwon et al. (2001) reported 
legal blindness (VA ≤20/200 and/or VF ≤20º at its widest diameter) from glaucoma in 
POAG with standard therapy in 13% of eyes at a follow-up of 14 years. Chen (2003) report-
ed in his retrospective analysis that at 15 years after diagnosis the Kaplan-Meier estimate 
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for glaucoma-related blindness (VA ≤20/200 and/or VF ≤20º in all quadrants) in one eye 
was 14.6%, and in both eyes 6.4%. Hattenhauer et al. (1998) presented higher fi gures at 20 
years’ follow-up; they estimated the probability of glaucoma-related blindness (defi ned as 
VA ≤20/200 and/or VF ≤20º at its widest diameter) in newly diagnosed classic open-angle 
glaucoma treated with medical, laser or surgical therapy or a combination of these methods 
in at least one eye to be 54%, and 22% for both eyes. Most studies have not considered 
various treatment modalities (medicine, laser, fi ltration surgery) separately.
Few studies have examined the probability of becoming blind after fi ltration surgery. Ac-
cording to Molteno et al. (1999), the probability of losing useful vision (VA ≤20/400 or VF 
≤5º radius) from any cause was 13%, 28%, and 40% at 5, 10, and 15 years, after trabeculec-
tomy, but only one-third was due to progression of glaucoma. Parc et al. (2001) reported 
higher fi gures, but the criteria were less severe (VA ≤20/200 and/or VF ≤20º at its widest 
diameter); according to Kaplan-Meier analysis, the probability of legal blindness in patients 
with OAG who underwent fi ltration surgery was 22% at 5 years and 46% at 10 years. In 
the Advanced Glaucoma Intervention Study (The AGIS Investigators 2004), the 10-year 
cumulative incidence of unilateral fi rst occurrence of VF impairment or visual acuity (VA) 
impairment (VA ≤0.2) or both in white patients in a trabeculectomy-ALT-trabeculectomy 
group was 30.4% from all causes.
Characteristics reported as risk factors for becoming blind because of glaucoma include 
more advanced fi eld defects at the time of surgery (Grant & Burke 1982, Parc et al. 2001, 
Chen 2003), poor preoperative visual acuity (Molteno et al. 1999), advancing age (Hat-
tenhauer et al. 1998), and noncompliance with the treatment regimen (Stewart et al. 1993, 
Chen 2003), as well as complete glaucomatous cupping of the optic disc, the mean IOP, 
variance of each patients’ IOP measurements and history of ALT (Stewart et al. 1993). In 
most studies, postoperative IOP was unrelated to blindness (Watson et al. 1990, Parc et al. 
2001, Chen 2003). The latest IOP was lower in blind eyes than in non-blind eyes, according 
to the fi ndings of Parc et al. (2001). Acute loss of vision after surgery (‘wipe-out’) may also 
occur (Costa et al. 1993).
2.2.11 Progression of cataract after trabeculectomy
The progression of a cataract is generally considered a late complication of trabeculectomy 
(The AGIS Investigators 2001). In a prospective study, at our hospital, Vesti (1993) identi-
fi ed EG, age, hypotony (IOP ≤5 mmHg lasting ≥5 days), and early postoperative IOP rise 
>30 mmHg after trabeculectomy to be risk factors for cataract progression. The indicators 
for cataract progression in that study were not limited to need for cataract extraction, but 
also included were deterioration in VA by ≥2 Snellen lines, myopic change in refraction, 
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and increase in lens opacity value, measured with a Lens Opacity Meter. Exfoliation 
syndrome has been suggested as a risk factor for progression of lens opacifi cation 
also in nonglaucomatous eyes (Puska & Tarkkanen 2001). In the Advanced Glaucoma 
Intervention Study (The AGIS Investigators 2001), increased risk for cataract was 
associated with age, diabetes, and postoperative complications of trabeculectomy; of 
the individual postoperative complications, marked infl ammation and fl at AC were 
statistically signifi cant.
2.2.12 IOP control after cataract surgery
Phacoemulsifi cation has an IOP-lowering effect both in healthy eyes and in unoper-
ated glaucomatous eyes (Peräsalo 1997, Pohjalainen et al. 2001). Pohjalainen (2001) 
discovered that after phacoemulsifi cation, 42% of POAG and 29% of EG eyes re-
quired less glaucoma medication at the last examination 1 to 3.7 years postoperatively 
than preoperatively. However, the effect of cataract surgery on IOP control in eyes 
that have undergone trabeculectomy seems to vary. Some studies show worsening of 
IOP control or greater number of antiglaucoma medications after phacoemulsifi ca-
tion (Chen et al. 1998, Crichton & Kirker 2001, Halikiopoulos et al. 2001, Casson et 
al. 2002, Derbolav et al. 2002, Rebolleda & Muñoz-Negrete 2002, Shingleton et al. 
2003), while others have noticed no negative effect of cataract surgery on IOP or on 
the number of glaucoma medicines overall (Park et al. 1997, Manoj et al. 2000, Mi-
etz et al. 2001). The proportion of eyes with continuing good control of IOP without 
antiglaucoma medication after cataract surgery was reported to be 33% by Mietz et 
al. (2001), but when eyes with improved IOP control after cataract surgery are added, 
the corresponding fi gure was 42%. In some other studies, the percentage of eyes with 
good postoperative IOP control has been higher (Crichton & Kirker 2001, Halikiopou-
los et al. 2001, Casson et al. 2002, Derbolav et al. 2002, Rebolleda & Muñoz-Negrete 
2002), partly because of the higher percentage of eyes with good IOP control before 
cataract surgery (up to 100% by Rebolleda & Muñoz-Negrete 2002). In most of the 
latter studies, cataract surgery was performed only on selected cases with functioning 
bleb and good IOP control before surgery.
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3. Aims of the present study
The purpose of the present study was to evaluate long-term outcome of trabeculectomy in 
POAG and EG.
The specifi c aims of the study were to evaluate:
 • preoperative characteristics of consecutive patients with POAG and EG who under-
went primary trabeculectomy during the study period (I).
 • long-term IOP control in POAG and EG after trabeculectomy with or without post-
operative medication (I). 
 • complication rate immediately after trabeculectomy and effects of early complications 
on long-term IOP control (II). 
 • location of trephined block and its effect on complications and long-term success (II).
 • degree of VF defect progression and development of low vision and blindness (III).
 • risk indicators leading to cataract surgery after trabeculectomy and effect of phacoe-
mulsifi cation on IOP control, and to evaluate cataract surgery in POAG and EG (IV). 
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4. Patients and methods
4.1 Patients
All primary trabeculectomies performed by one surgeon (I.L.) at the Helsinki University 
Eye Hospital between November 1994 and August 1996 were studied retrospectively in 
1998–1999 (263 eyes). Helsinki University Eye Hospital ethics committee approval was 
obtained for the study. Only eyes with POAG (not including normotensive glaucoma) or 
EG were included. Diagnoses of POAG and EG were based on preoperative defi nitions 
at the glaucoma unit. Patients under 40 years of age at the time of the operation and all 
the eyes operated on with the use of antimetabolites were excluded (29 eyes) (Fig.1). The 
33 eyes of patients who died before the follow-up examination were also excluded. In 23 
cases, both eyes of a patient had been operated on during the study period; only one eye of 
each of these patients was randomly chosen for the study. Ten patients did not answer the 
Figure 1. Flowchart of the study patients
All trabeculectomies (n=263)
Antimetabolite use
<40 years of age
(n=29)
Bilateral cases; one
eye randomly chosen
to be excluded (n=23)
Eyes of patients
dying before follow-up
examination (n=33)
Patients not responding to
invitation letter (n=10)
Eyes of patients with other
glaucoma types (n=30)
POAG
(n=55)
EG
(n=83)
138 eyes
201 eyes
▼
▼
▼
▼
▼
▼
▼
▼
▼
POAG = primary open-angle glaucoma, EG = exfoliation glaucoma
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letter of invitation. Thus 138 eyes comprised the study series. Of these, 102 patients were 
examined by the author at the end of the follow-up period in 1998–1999. In 36 cases, infor-
mation for follow-up came from the patient’s charts or from the referring physician.
From the analysis of VF progression (III), 55 of the 138 eyes were excluded because in 36 
cases the preoperative fi elds (in 18 cases Octopus G1 and in 18 cases Goldmann VF) had 
been measured more than 3 months before the operation, in 6, patients had different kinds 
of fi elds pre- and postoperatively, and in 13 cases, the fi elds were unavailable for reasons 
such as dementia or loss of co-operation.  Thus, at the last follow-up visit, comparable 
pre- and postoperative VF, measured by the same technique were available for 83 patients 
(60%), Octopus G1 fi elds for 40 eyes, and Goldmann fi elds for 43 eyes.
During the follow-up, of the 138 eyes, 48 (35%) underwent a cataract operation. One eye 
with endophthalmitis after trabeculectomy and one lacking information as to cataract sur-
gery were excluded from further analysis of cataract surgery. The remaining 46 eyes are 
included in the study on cataract surgery (IV).
4.2 Methods
4.2.1 Clinical data recorded retrospectively
Clinical data on the patients were collected from the fi les of the Helsinki University Eye 
Hospital and from private ophthalmologists responsible for their referral and follow-up. 
Preoperative data collected included date of birth, gender, type of glaucoma, preoperative 
medication and its duration, dates of all surgical interventions including laser operations, 
best corrected visual acuity (BCVA) recorded as Snellen decimal notations, refraction, IOP, 
anterior segment status, posterior pole abnormalities, optic disc appearance, and results of 
visual fi eld examinations. The preoperative IOP, was considered to be the value measured 
by Goldmann applanation tonometry at the visit immediately prior to trabeculectomy.
Intra- and postoperative complications of trabeculectomy (early postoperative IOP eleva-
tion >30 mmHg, hyphema, hypotony <5 mmHg ≥5 days, leakage of the fi ltering bleb, a 
shallow or fl at AC, choroidal detachment, infection, cystoid macular oedema (CME), hy-
potony maculopathy, suprachoroidal haemorrhage, persistent uveitis and dellen formation) 
and any additional postoperative procedures were recorded (LSL, resuturation, reformation 
of the anterior chamber, or posterior sclerotomy). 
Postoperative IOP values measured on the fi rst postoperative day after trabeculectomy and 
one week and one month postoperatively were collected. 
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4.2.2 Data recorded at the follow-up examination
At the last follow-up visit, BCVA, refraction, IOP, anterior segment status including the 
lens, posterior pole status, and optic disc appearance were examined mostly by the author 
by standard clinical methods. Visual fi elds were examined with the same VF program as 
preoperatively. In addition, medications used and information concerning any additional 
operations (retrabeculectomy or cyclophotocoagulation) during the follow-up period were 
recorded. The date when glaucoma medication had been restarted came from the referring 
physician. In eyes having cataract surgery (IV) BCVA, IOP and medications used before 
the cataract operation, and details of cataract surgery including the technique and the inci-
sion used, and intraocular lens (IOL) type and placement, as well as intra- and postopera-
tive complications were all recorded. 
4.2.3 Indications and technique of trabeculectomy
Indications for trabeculectomy were uncontrolled IOP despite maximal tolerated medica-
tion or disease progression or both. All operations were performed by one senior surgeon 
(I.L.). The use of warfarin sodium or acetyl salicylic acid was discontinued 1 to 3 days 
before surgery. A limbus-based conjunctival fl ap was used, beginning about 5 mm poste-
rior to the limbus. A rectangular 3 × 4 mm scleral fl ap extended into the clear cornea. Two
10–0 nylon sutures were preplaced in the corners of the fl ap. Trabeculectomy was per-
formed with a 1.3 mm Geuder motor trephine. After peripheral iridectomy, the fl ap was 
closed with two to four sutures. Tenon and conjunctiva were reapproximated separately 
with 8–0 Vicryl sutures, and periocular injections of cefotaxime (Claforan®) and triamci-
nolone (Kenacort™) were given at the end of the operation. Postoperatively, topical atro-
pine t.i.d., antibiotics q.i.d.,  and steroids q.i.d. were given for up to 1 month.
4.2.4 Defi nitions of complete success, qualifi ed success, and failure (I–IV)
In terms of IOP, trabeculectomy was considered a complete success if IOP was 21 mmHg 
or lower without other therapy, a qualifi ed success if IOP was 21 mmHg or lower with a 
single topical medication, and a failure if IOP was more than 21 mmHg or if an eye with 
lower IOP received more medications or had required further surgery, except laser suture 
lysis, because of glaucoma. 
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4.2.5 Examination of the trephined tissue block (II) 
Of the 138 eyes, in 118 (86%), the trephined tissue block had been examined at the pa-
thology laboratory of the Helsinki University Eye Hospital by one senior ophthalmologist 
(L.M.).  The surgical specimen was fi xed in 4% formalin, embedded in paraffi n, cut, and 
stained with haematoxylin and eosin and with PAS stains. The cut sections were evaluated 
for the presence of identifi able landmarks, including Descemet’s membrane, trabecular tis-
sue, Schlemm’s canal, and ciliary muscle. The location of a trabeculectomy was defi ned 
as anterior if any Descemet’s membrane in addition to trabecular tissue was visible in the 
specimen. The specimens containing trabeculum only, with or without ciliary muscle but 
no Descemet’s membrane, were defi ned as posterior.
4.2.6 Evaluation of visual fi elds and progression of defects (III)
Preoperatively, VF had been examined by either automated static perimetry using the Oc-
topus G1 program or by kinetic Goldmann perimetry, depending on the patient’s capability 
to respond at the fi eld examination. Degree of VF loss before surgery was scored as (1) 
mild to moderate or (2) severe by a modifi cation of the classifi cation originally described 
by Aulhorn (1978). The degree was severe if there was an extensive ring-shaped or half-
ring-shaped absolute defect in the paracentral VF area extending up to 30º with or without 
a central island. In addition, all absolute scotomas within the central 5º, or a mean defect 
worse than –16 dB in the Octopus fi eld (Heijl et al. 2002) was regarded as severe. 
For progression of Octopus G1 VF defects, the criteria were those presented by the Glau-
coma Laser Trial Research Group (Glaucoma Laser Trial Research Group 1995); progres-
sion is a change in each of two spots in the central 30 degrees of fi eld showing any of the 
following characteristics: (1) threshold value 7 dB or more below the threshold value of an 
abnormal spot on the fi eld of reference (deepening of an existing scotoma), (2) threshold 
value 9 dB or more below the threshold value of a normal spot adjacent to an abnormal 
point on the fi eld of reference (enlargement of an existing scotoma), or (3) threshold value 
11 dB or more below the threshold value of a normal spot on the fi eld of reference (new 
scotoma). False-positive or false-negative rates greater than 20% indicated unreliability. 
Progressive loss of the Goldmann VF was defi ned as a defi nitive reduction in a fi eld area or 
an extension toward fi xation of a paracentral scotoma that was due to glaucoma (Molteno et 
al. 1999). The estimation of the progression of Goldmann VF was based on clinical judge-
ment and agreement by two of the authors. In 68% of the cases (23 of 34 eyes), progression 
of the VF defect was confi rmed by re-examination of VF, or by discovery of loss of fi xation 
or concurrent optic disc changes. In 6 of the remaining 11 cases, high IOP at or above the 
preoperative level supported the conclusion of progression.
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4.2.7 Visual acuity and defi nition of visual impairment (III)
BCVA was recorded as Snellen decimal notations. For comparison of pre- and postopera-
tive values, the VAs were scored in four categories: ≥0.5, <0.5 to 0.3, <0.3 to 0.05, and 
<0.05. The two lower categories correspond to low vision (VA <0.3 to 0.05) and blindness 
(VA <0.05) according to the WHO defi nition (World Health Organization 1980). In addi-
tion, eyes with a VF constricted to less than 20˚ at its widest diameter without considering 
central VA were defi ned as blind. The cause of visual impairment was categorized as glau-
coma-related if no other cause was discovered.
4.2.8 Indications and technique of cataract surgery (IV)
In a retrospective study, the indications for cataract surgery may have varied in individ-
ual cases. Cataract surgeries were performed by experienced surgeons, who in 45 of the
46 cases used the phacoemulsifi cation technique. Of these cases, two were converted to
extracapsular cataract extraction (ECCE) and one to intracapsular cataract extraction (ICCE) 
because of problems with phacoemulsifi cation, and one additional ECCE was planned. The 
technique was roughly similar for all cases. A temporal 5.5-mm scleral tunnel incision was 
used in 40 eyes, and a clear corneal incision in 5. Thus, in uncomplicated cases, the area of 
trabeculectomy bleb located superiorly could be avoided. Sphincterotomies were cut in six 
eyes. An intraocular lens (IOL) was implanted in all eyes, in the capsular bag in 40 eyes: 
In 4 eyes a foldable lens and in 34 a polymethylmethacrylate (PMMA) lens was used, in 2 
cases, information on lens type was lacking. In four eyes, a PMMA lens was implanted in 
the ciliary sulcus, and two eyes received an anterior chamber intraocular lens (AC IOL). 
In most uncomplicated cases, the incision was self-sealing. In 14 eyes, it was closed with a 
10–0 nylon suture, and the conjunctiva with silk. Two eyes had anterior vitrectomy, and in 
one of them vitrectomy via pars plana and removal of a piece of nucleus were performed 
6 days after phacoemulsifi cation. Periocular cefotaxime and triamcinolone injections were 
given in 30 cases; in 7 cases cefuroxime 1 mg was injected into the anterior chamber, and 
9 eyes received no intraocular or periocular injections. Postoperative medication included 
topical antibiotics and steroids or non-steroidal anti-infl ammatory drugs q.i.d. for 4 weeks. 
4.2.9 Statistical methods
Data were collected in Microsoft Excel 97 (Seattle,WA), and analysed by standard statisti-
cal methods, by GraphPad Prism™ 2.01. and the NCSS 2000 program from NCSS Statisti-
cal Software. Unpaired Student’s (two-sample) t-test or the Mann-Whitney test were used 
for comparison of the continuous variables between the groups. The chi-square test or Fish-
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er’s exact test were used to evaluate the signifi cance of the differences between categorised 
data. Differences between pre-trabeculectomy IOP and last IOP, pre- and last post-cataract 
surgery IOP, and pre- and last post-cataract surgery topical medication within the POAG 
and EG groups were calculated with the paired t-test and Wilcoxon signed-rank test, as ap-
propriate. Pearson’s correlation was performed to detect the correlation between the lowest 
IOP within the fi rst postoperative month after trabeculectomy and the last IOP. The success 
rates of IOP control in the different groups were analysed with Kaplan-Meier analysis. The 
signifi cance level of the difference between the groups in the Kaplan-Meier survival curves 
was calculated with the log-rank test. Proportional hazards regression was used to detect 
multivariate infl uences on the success of trabeculectomy. Proportional hazards regression 
was also used to estimate risk indicators for cataract surgery. Logistic regression was per-
formed to detect multivariate infl uences on progression of visual fi eld defects. A p-value of 
0.05 was considered signifi cant.
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5. Results
5.1 Preoperative patient characteristics (I) 
Of the 138 patients included, 83 (60%) were females and 55 (40%) males. The mean age 
of the patients on trabeculectomy day was 70.1 years (range 41-90 years). All patients were 
Caucasian.
Fifty-fi ve eyes (40%) had POAG, and 83 (60%) had EG (Table 4). The proportion of males 
was slightly but not signifi cantly greater in the POAG group. Patients with POAG were sig-
nifi cantly younger (p=0.03), but the duration of their glaucoma was slightly longer (p=0.06). 
Of both POAG and EG eyes, 98% were receiving topical medication, and 84% and 86% of 
them, respectively, were receiving two or more medications. The mean number of topical 
antiglaucoma medicines was 2.1 (SD 0.7) in both groups. In addition, more than half the 
patients were taking oral antiglaucoma medication. ALT had been performed in 28 eyes 
with POAG (51%) and in 47 eyes with EG (57%). Three eyes in the POAG group, and two 
in the EG group had undergone diode laser cyclophotocoagulation before trabeculectomy. 
Table 4. Patient characteristics according to type of glaucoma
 POAG EG p
Number of eyes 55 83
Age (mean, years) (SD) 67.8 (10.8) 71.6 (9.2) 0.03
 range 40.6–88.6 50.4–90.2
Gender M/F (%) 24/31 (44%/56%) 31/52 (37%/63%) 0.46
Duration of preoperative
glaucoma medication
 (mean, years) (SD) 7.8 (5.6) 5.8 (6.3) 0.06 
 range 0–19.7 0–34.6
Preoperative ALT (%) 28 (51%) 47 (57%) 0.51
Preoperative IOP 
 (mean, mmHg) (SD) 24.6 (5.8) 28.0 (11.2) 0.044 
 range 13–37 14–70
 (95% Cl) (23.1–26.2) (25.5–30.4)
POAG = primary open-angle glaucoma, EG = exfoliation glaucoma, ALT = argon laser trabecu-
loplasty, IOP = intraocular pressure
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Before trabeculectomy, the mean IOP was 24.6 (SD 5.8) mmHg in the POAG group and 
28.0 (SD 11.2) mmHg in the EG group (p=0.044). Of the 83 eyes in which comparison be-
tween pre- and postoperative VF could be made, the preoperative VF defect was considered 
severe in 33 eyes (40%) and mild to moderate in 50 (60%). Of the severe defects, 20 (61%) 
were discovered by Goldmann perimetry, 13 (39%) by Octopus perimetry.  
5.2 Outcome of trabeculectomy in terms of intraocular pressure (I)
All patients were followed up for at least 2 years (mean 3.5 years, range 2–5). At the last 
examination, the mean IOP in the POAG group was 16.6 (SD 4.2) mmHg and in the EG 
group 17.1 (SD 6.2) mmHg (p=0.95) (Table 5). Mean reduction in IOP from the preopera-
tive level was highly signifi cant in both groups (p<0.0001). The fi nal IOP was lower than 
the preoperative level in 84% of eyes. However, 45% of POAG eyes and 58% of EG eyes 
were on glaucoma medication, and 24% and 37% of them were receiving two or more 
medications (p=0.15). The mean number of topical antiglaucoma medicines was 0.8 (SD 
1.0) in POAG and 1.1 (SD 1.1) (p=0.11) in EG. Of POAG eyes 11% and of EG eyes 13% 
(p=0.68) had undergone additional glaucoma surgery.
Table 5. Postoperative data according to type of glaucoma
 POAG EG p
Number of eyes 55 83
Last postoperative IOP
 (mean, mmHg) (SD) 16.6 (4.2) 17.1 (6.2) 0.95
 range 1–28 0–46
 (95% Cl) (15.5–17.7) (15.8–18.5)
Absolute decrease in IOP
 (mean, mmHg) (SD) 8.0 (7.9) 10.8 (13.7) 0.35
 (%) (28%) (30%)
Number of eyes receiving
 topical medication (%) 25 (45%) 48 (58%) 0.15
Number of topical 
 medication (mean, SD) 0.8 (1.0) 1.1 (1.1) 0.11
Follow-up after trabeculectomy  
 (mean, months) (SD) 42.8 (8.1) 42.2 (8.2) 0.64
POAG = primary open-angle glaucoma, EG = exfoliation glaucoma, IOP = intraocular pres-
sure
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According to the Kaplan-Meier survival curve, success rates for the IOP control, including 
both complete and qualifi ed success in the whole series, were 82% at 1 year, 70% at 2 years, 
64% at 3 years, and 52% at 4 years. Rates for complete success were 63%, 54%, 45%, and 
40% (Fig. 2). Complete success was signifi cantly more common in eyes with POAG than 
in eyes with EG (p=0.04), but with qualifi ed success included, the difference was not sig-
nifi cant (p=0.1).
Figure 2. Kaplan-Meier survival analysis of complete and complete or qualifi ed success rates of 
the intraocular pressure (IOP) control in the whole series
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In POAG, 79% of eyes with complete success had received longstanding preoperative topi-
cal medication (>3 years), while in EG, the corresponding percentage was 43% (p=0.008). 
Thus it seems that the longstanding preoperative medication reduced chances of complete 
success in EG. 
In multivariate analysis (proportional hazards regression) signifi cant factors affecting com-
plete success in the long term were the presence of EG (p=0.03) and an early postopera-
tive peak of IOP over 30 mmHg (p=0.04), both worsening prognosis, whereas a cataract 
operation (p=0.02) improved the chances that an eye remained a complete success. When 
complete and qualifi ed success were combined, no signifi cant predictors of success could 
be found. The following characteristics were tested: age, gender, duration of glaucoma, 
number of preoperative medications, preoperative ALT, preoperative IOP, glaucoma di-
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agnosis (POAG or EG), early postoperative peak of IOP over 30 mmHg,  macroscopic 
hyphema during the fi rst postoperative week, postoperative hypotonia defi ned as IOP less 
than 5mmHg lasting at least 5 days, and a cataract operation performed before an eye had 
to be considered a qualifi ed success or a failure.
5.3 Complication rate immediately after trabeculectomy (II)
In the whole study group, the early postoperative complications included hyphema in 17%, 
marked hypotony (<5mmHg ≥5 days) in 25%, a shallow or fl at AC in 15%, and choroidal 
detachment in 21%, with some of these complications occurring simultaneously.
Postoperative hyphema was the only complication that differed signifi cantly between 
POAG and EG (p=0.011) (Table 6). Previous warfarin or acetyl salicylic acid medication 
did not affect the hyphema rate signifi cantly in either group, and no difference existed in 
preoperative IOP between eyes with or without hyphema. In the EG group, the number of 
preoperative drops was signifi cantly higher in the hyphema cases (p=0.01), but otherwise 
the eyes with hyphema did not differ from those without. Two hyphema cases resulted di-
rectly from LSL (2.9% of eyes with LSL).
Table 6. Early postoperative complications within one month after trabeculectomy in patients 
with POAG and EG
Complication POAG EG All eyes
 Number of eyes (%)  Number (%)
 55 83 138
Hyphema 4 (7%)* 20 (24%)* 24 (17%)
Early postoperative 
 IOP elevation >30 mmHg 8 (15%) 17 (20%) 25(18%)
Hypotony <5mmHg  ≥5days 13 (24%) 21 (25%) 34 (25%)
Leakage of fi ltering bleb 2 (4%) 6 (7%) 8 (6%)
Shallow or fl at AC 7 (13%) 14 (17%) 21 (15%)
Choroidal detachment 11 (20%) 18 (22%) 29 (21%)
Endophthalmitis 1 (1.8%) 0 (0%) 1 (0.7%)
Bacterial conjunctivitis 0 (0%) 2 (2.4%) 2 (1.4%)
Fibrinous reaction in AC 1 (1.8%) 1 (1.2%) 2 (1.4%)
POAG = primary open-angle glaucoma, EG = exfoliation glaucoma, IOP = intraocular pressure, 
AC = anterior chamber
* p=0.011
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Early postoperative IOP elevation (IOP >30 mmHg) was equally common in POAG (15%) 
and EG (20%). Altogether 70 eyes (51%) received LSL, and 22 eyes (16%) were put on 
pressure-lowering medication at the end of the fi rst month because of insuffi cient fi ltration 
(despite LSL in 13 of them). Of these eyes, 6 (27%) had POAG and 16 (73%) EG. Four 
of these patients were found to be steroid responders; in these eyes, glaucoma medication 
could be reduced during the fi rst 6 postoperative months. One eye had insuffi cient fi ltration 
following postoperative endophthalmitis. Insuffi cient fi ltration (antiglaucomatous medica-
tion) at the end of the fi rst postoperative month predicted long-term failure (p=0.0084), but 
failure did not correlate with any of the other early complications or LSL. 
One or more complications related to excessive fi ltration occurred in 45 eyes (33%); in 
30 of them, several complications. A shallow anterior chamber was recorded in 21 eyes 
(15%), with iridocorneal contact in 8 eyes. Reformation of the anterior chamber with or 
without  posterior sclerotomy was indicated in seven eyes, in four of which the scleral fl ap 
was resutured. No signifi cant correlation appeared between the lowest IOP within the fi rst 
postoperative month and the latest IOP, nor was there any correlation between lowest post-
operative pressure and success (complete or qualifi ed).
Of 70 eyes, in 6 (9%), LSL was followed by excessive fi ltration, and 5 of these eyes had 
several complications. Two iris incarcerations into two trabeculectomy fi stulas, and two 
cases of hyphema resulted directly from LSL. Except for the two iris incarcerations, which 
were treated with the YAG laser, all the other complications related to LSL resolved with 
conservative treatment.
5.4 Effect of position of trephined block in the anterior chamber angle 
(II)
In 60 eyes, trabeculectomy was defi ned as anterior, and in 53 eyes as posterior. Patient char-
acteristics did not differ signifi cantly between those patients with eyes having anterior and 
those having posterior trabeculectomy among POAG or EG patients. Postoperative hyphe-
mas were equally common in the anterior and posterior trabeculectomy group. Hypotony 
of <5 mmHg for at least 5 days, a fl at or shallow AC, and choroidal detachment were more 
common, although not signifi cantly so, in the anterior group. 
The long-term success rates for both complete success and qualifi ed success did not sig-
nifi cantly differ between the anterior and the posterior groups in the Kaplan-Meier survival 
analysis, but a tendency appeared for the posterior location to survive better in the EG 
group.
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5.5 Progression of visual fi eld defects after trabeculectomy (III)
Of the 83 eyes for which a comparison between pre- and postoperative VF could be made, 
the VF remained stable in 37 eyes (45%). In 34 cases (41%), progression of glaucoma-
tous fi eld defects was classifi ed as undisputable, and in 6 (7%), progression of defects was 
suspected, but some of these fi elds were unreliable, or progression may have been due to 
changes in the macula. Six eyes (7%) had other causes for progression of fi eld defects (in 
one each, neovascular glaucoma, cerebral infarction, cataract, endophthalmitis; two had 
central retinal vein occlusion). 
The preoperative VF defect was considered severe in 33 eyes (40%) and mild to mod-
erate in 50 (60%). Of the 33 severe defects, 20 (61%) showed undisputable progression 
compared to 14 of 50 cases (28%) of mild to moderate defects. Thus, of the 34 fi elds that 
showed progression of defects, 20 (59%) were preoperatively classifi ed as severe (with 8 
cases of Octopus G1) and 14 (41%) as mild or moderate (with 8 cases of Octopus G1).
5.6 Risk indicators for progression of visual fi eld defects (III)
VF progression was slightly but not signifi cantly more common in EG (52%) than in 
POAG (40%) (p=0.33). In logistic regression analysis only severe preoperative VF defect 
(p=0.0047) and preoperative oral glaucoma medication (p=0.047) were signifi cantly re-
lated to VF progression.
In univariate analysis, initial IOP reduction from preoperative to 1-month follow-up (15.4 vs. 
10.9 mmHg) and IOP reduction from preoperative to last postoperative examination (12.8 
vs. 9.2 mmHg) were signifi cantly smaller in eyes with VF defect progression, (p=0.023, 
p=0.036, respectively). But the mean IOP at the last examination, 16.3 (SD 3.8) mmHg in 
eyes without progression and 17.6 (SD 7.4) mmHg in eyes with progression (p=0.58), or 
the mean number of topical antiglaucoma medicines, 0.76 (SD 0.95) and 1.03 (SD 0.97), 
respectively (p=0.2), did not differ. Nor was the difference in mean percentage IOP reduc-
tion (39.4 vs. 26.4%) from the preoperative to the last examination signifi cant (p=0.095). 
Progression of VF loss did not correlate signifi cantly with success rate when an IOP level 
21 mmHg or lower (without or with a single medication) or an IOP level less than 18 mmHg 
(without medication or additional surgery) at the last follow-up visit served as the marker. 
Nine eyes had an IOP of less than 13 mmHg at the last examination without medication or 
additional glaucoma surgery during the follow-up period, but despite the low IOP, in three 
of these eyes, VF defects progressed.
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5.7 Development of low vision and blindness after trabeculectomy (III)
Preoperatively, 13 (9%) of the 138 eyes had low vision, and one eye (0.7%) was blind based 
on visual acuity and 5 eyes due to restriction of VF (Table 7). One patient was bilaterally 
blind. At the last follow-up visit, 19 eyes (14%) had low vision, and 7 (5%) were blind by 
VA criteria and 10 (7%) due to constriction of the VF. Of the 26 eyes with visual impair-
ment by VA criteria, 15 were considered glaucoma-related, and 11 were due to other causes 
(cataract in 5, cellophane maculopathy or pucker in 2, and in 1 each, endophthalmitis, 
central retinal vein occlusion, and neovascular glaucoma; for 1 eye postoperative VF was 
unavailable). During the mean follow-up of 3.5 years, the prevalence of glaucoma-related 
low vision had increased from 6% to 7% and that of blindness from 4% to 10% in the oper-
ated eye. Two patients were bilaterally blind. 
Table 7. Prevalence of low vision (VA <0.3–0.05) and blindness (VA <0.05 or VF constricted to 
less than 20º at its widest diameter) in the operated eye preoperatively and at the last follow-up 
examination
 All causes  Glaucoma-related
  Number of eyes (%)
 Preoperative Last Preoperative Last
Low vision 
 VA criteria 13 (9.4%) 19 (13.8%) 8 (5.8%) 10 (7.2%)
Blindness
 VA criteria 1 (0.7%) 7* (5.1%) 1 (0.7%) 5** (3.6%)
 VF criteria only 5 (3.6%) 10 (7.2%) 5 (3.6%) 9 (6.5%)
 All blindness 6 (4.3%) 17 (12.3%) 6 (4.3%) 14 (10.1%)
VA = visual acuity, VF = visual fi eld
* 2 eyes fulfi lled also VF criteria for blindness, ** 1 eye fulfi lled also VF criteria for blindness
Visual impairment (low vision and blindness) at the last visit correlated signifi cantly 
(p=0.008) with severe VF defect preoperatively.
5.8 Risk indicators for cataract surgery (IV)
During the follow-up period, 48 eyes (35%) underwent cataract surgery. Of these, 46 were 
analysed in detail. One eye with endophthalmitis after trabeculectomy and one lacking in-
formation as to cataract surgery were excluded. The 46 cataract operations were performed 
5.1 to 58.1 months (median 14.4) after trabeculectomy. Mean follow-up after cataract sur-
gery was 25.3 (SD 12.9) months (median 24.8). 
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Patients undergoing cataract surgery during the follow-up were signifi cantly older (73.9 
(SD 9.4) years) at the time of trabeculectomy than those without the operation (68.1 (SD 
9.8) years) (p=0.001), and eyes with a cataract operation had worse initial BCVA before 
trabeculectomy than did eyes without cataract surgery (Fig. 3). The following characteris-
tics: gender, type of glaucoma, duration of glaucoma, number of preoperative medications, 
ALT before trabeculectomy, pre-trabeculectomy IOP, early postoperative peak of IOP >30 
mmHg after trabeculectomy, macroscopic hyphema during the fi rst postoperative week, hy-
potony defi ned as IOP <5 mmHg lasting at least 5 days after trabeculectomy, or shallow or 
fl at AC, did not differ between eyes with cataract operation and those without (proportional 
hazards regression).
Figure 3. Visual acuity before trabeculectomy in eyes with and without cataract surgery
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5.9 Effect of phacoemulsifi cation on intraocular pressure (IV)
Before cataract surgery, the mean IOP was 16.2 (SD 4.9) mmHg and the mean number of 
topical antiglaucoma medicines was 0.8 (SD 1.0). One patient took oral antiglaucoma med-
ication. At the last examination, the mean IOP 17.3 (SD 6.4) mmHg was not signifi cantly 
higher than before cataract surgery (p=0.35), but the mean number of topical antiglaucoma 
medicines had increased signifi cantly to 1.3 (SD 1.1) (p=0.0007). In addition, 3 patients 
required oral antiglaucoma medication.
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Prior to cataract surgery, 22 of the 46 eyes (48%) were categorized as complete success, 10 
eyes (22%) as qualifi ed success, and 14 eyes (30%) as failures. Of the 14 failures, 11 (79%) 
had an IOP of 21 mmHg or lower but required two or three medicines or had undergone 
cyclophotocoagulation (4 eyes) before cataract surgery. 
Of the 22 eyes categorized as a complete success prior to cataract surgery, 13 (59%) had re-
mained so, one eye had become a qualifi ed success (requiring one topical medicine), and 8 
eyes (36%) were failures at the last examination. Altogether, the number of failures in these 
eyes had increased from 14 (30%) before surgery to 28 (61%) after cataract surgery. Of the 
14 new failures, 7 had IOP <21 mmHg but required two topical medicines. The proportion 
of failures in the cataract surgery group was twice as high as in eyes with no cataract sur-
gery (61% vs. 31%, p=0.0016) (Fig. 4). Of the nine eyes with complicated cataract surgery, 
six were failures at the last examination.
Figure 4. Kaplan-Meier survival analysis of complete or qualifi ed success rates of intraocular 
pressure (IOP) control in eyes with and without cataract surgery
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In 19 of the 46 eyes (41%), use of topical antiglaucoma medicines had increased after 
cataract surgery. At the last examination, 70% of eyes with cataract surgery and 44% of 
eyes with no cataract surgery (p=0.006) were on glaucoma medication, and 52% and 24% 
of them, respectively (p=0.001), were receiving two or more medications. In the cataract 
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group, one eye had undergone retrabeculectomy and cyclophotocoagulation, and four eyes 
cyclophotocoagulation before cataract surgery, and four eyes had cyclophotocoagulation 
after  cataract surgery (a total of 9 eyes).  In eyes with no cataract surgery, one eye had
undergone retrabeculectomy and 6 eyes cyclophotocoagulation during the follow-up (a to-
tal of 7).
5.10 Cataract surgery in primary open-angle glaucoma and exfoliation 
glaucoma (IV)
Of the 46 eyes with cataract surgery, 14 eyes (30%) had POAG, and 32 (70%) had EG. 
Cataract surgery was, however, not signifi cantly more common in eyes with EG than in 
those with POAG (p=0.09). The other parameters in Table 8 also did not differ signifi cantly 
between these groups. Cumulative probability of cataract surgery in POAG and EG was 
similar during the fi rst year of follow-up, but after that, the probability increased in EG to 
40% and in POAG to 26% (Fig. 5). 
Table 8. Patient characteristics in cataract surgery group according to type of glaucoma 
 POAG EG p
Number of cataract operations (%) 14/55 (25.5%) 32/81 (39.5%) 0.09
Age on trabeculectomy day 
 (mean, years) (SD) 71.2 (11.6) 75.1 (8.1) 0.21
Time from trabeculectomy to cataract surgery 
 (mean, months) (SD)  18.6 (11.0) 17.6 (11.2) 0.9
 median 15.4 14.4
Follow-up after cataract surgery
 (mean, months) (SD) 24.3 (13.2) 25.7 (12.9) 0.7
IOP before cataract surgery
 (mean, mmHg) (SD) 15.7 (5.5) 16.3 (4.7) 0.9
IOP at last visit
 (mean, mmHg) (SD) 16.2 (6.1) 17.8 (6.5) 0.9
Topical medication before
 cataract surgery (n) 0.7 (1.0) 0.9 (1.0) 0.5
Topical medication
 at last visit (n) 1.3 (1.2) 1.4 (1.1) 0.8
POAG = primary open-angle glaucoma, EG = exfoliation glaucoma, IOP = intraocular pres-
sure
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Figure 5. Cumulative probability of cataract surgery in primary open-angle glaucoma 
(POAG) and exfoliation glaucoma (EG) 
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6. Discussion
6.1 Selection of patients
The principal aim of this study was to determine in OAG eyes the success rate for long-term 
IOP control after primary conventional trabeculectomy and the need for further antiglau-
comatous treatment either medical or surgical. Based on clinical experience and on the 
literature, in the high-risk cases including young patients, black patients, eyes with previ-
ous ocular surgery (failed trabeculectomy), trauma, aphakia, active uveitis or neovascular 
glaucoma, the routine fi ltration surgery often will fail (Broadway & Chang 2001). In these 
high-risk eyes, antimetabolites together with conventional fi ltering surgery or drainage-
device implantation is often indicated. This study excluded the high-risk cases. In addi-
tion, eyes with normotensive glaucoma were excluded, because the criteria for successful 
postoperative IOP level are different from POAG or EG. Thus the study group consisted 
of a consecutive series of primary trabeculectomies performed by one experienced surgeon 
on eyes with POAG and EG. For statistical reasons, only one eye per patient was included. 
When the 33 patients of the whole series who had died before the follow-up examination 
were also excluded, data were available for 138 (93%) eyes.
Due to the common occurrence of exfoliation syndrome in Finland (Lindberg 1917, 
Tarkkanen 1962, Krause 1973, Peräsalo & Raitta 1992, Hirvelä et al. 1995) and the poorer 
response of EG to medical treatment, the proportion of EG in this series was high (60%), in 
contrast to most previous studies’. High percentages of EG have also been reported in other 
Nordic studies; 64% (Törnqvist & Drolsum 1991) and 56% (Popovic & Sjöstrand 1999) of 
all patients in each study. 
6.2 Choice of methods
This study is a retrospective single-surgeon series of consecutive primary trabeculectomies. 
By primary trabeculectomy, we mean the fi rst fi ltrating surgery performed on an eye. The 
main indications for surgery were uncontrolled IOP or progression of VF or optic disc de-
fects despite maximal tolerated medication. During the period of surgery (November 1994 
to August 1996), the technique of trabeculectomy remained fairly unchanged. 
Patients were examined by standard clinical methods. The fi nal clinical examination was 
performed by the author in 102 (74%) of the cases and by one of the coauthors in another 17 
cases (12%). Thus, the clinical examinations of the patients were comparable. The patients 
were followed up for 2 to 5 years (mean 3.5 years).
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The retrospective nature of the study caused some problems, particularly in the evaluation of 
the VF changes. In 36 cases, the preoperative VF had been performed more than 3 months 
before trabeculectomy, and 6 patients had different kinds of VF examination methods pre- 
and postoperatively. These cases were excluded from the VF comparison, and in 13 cases 
fi elds were unavailable for reasons like dementia or loss of cooperation. Thus, VF defect 
progression could not be estimated in every case. In the clinical routine, the goal of many 
prospective glaucoma studies, to examine automated perimetry repeatedly to exclude vari-
ation between examinations (Heijl et al. 1989, The AGIS Investigators 1994), could not be 
fulfi lled in every case. In this unselected series, because many of the patients were not ca-
pable of performing automated perimetry reliably, kinetic perimetry was used in more than 
half the cases (52%) refl ecting the diffi culty of the perimetry and the severity of the cases.
In a retrospective study, the indications for cataract surgery may have varied in individual 
cases. Cataract surgery was performed by experienced surgeons using the phacoemulsifi ca-
tion technique whenever possible.
6.3 Outcome of trabeculectomy in terms of IOP
No standard defi nition exists for the success of glaucoma surgery with regard to IOP, be-
cause no single target pressure can be regarded as a safe limit for disease control in all 
individual eyes (Kidd & O’Connor 1985, Popovic & Sjöstrand 1991, Singh et al. 2000, 
Palmberg 2002). We used the limit of 21 mmHg because it makes this study comparable 
with most of the other studies on the same topic. In some studies, a reduction in IOP of at 
least 20% or 33% from the presurgical level has served as an additional criterion for success 
(Nouri-Mahdavi et al. 1995, Chen et al. 1997, Edmunds et al. 2001), and some have used 
progression of VF defects as a defi nition of failure (Törnqvist & Drolsum 1991).
With an IOP level of 21 mmHg as the defi nition of success, the success rate in previous 
studies has ranged between 48% and 98% depending on follow-up time. The success rate 
has been shown to decrease with time (Popovic & Sjöstrand 1991, Chen et al. 1997, Briggs 
& Jay 1999, Molteno et al. 1999). In the present study, the one-year success rate, defi ned 
as an IOP of 21mmHg or lower without medication or with a single medicine, was 82%, 
corresponding to the best previous results without medication in OAG (Watson & Grier-
son 1981, Briggs & Jay 1999, Edmunds et al. 2001), but it gradually decreased to 52% at 
4 years. Similar long-term fi gures using different criteria have been presented (Jerndal & 
Lundström 1980, Törnquist & Drolsum 1991, Nouri-Mahdavi et al. 1995). At the last ex-
amination, 53% of the eyes were on antiglaucomatous medication, and 12% had had further 
glaucoma surgery during the follow-up period, indicating the importance of regular long-
term follow-up after trabeculectomy. 
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In the present study, complete success was signifi cantly more common in eyes with POAG 
than in eyes with EG. A lower success rate without medication in exfoliation eyes has 
been observed (Mills 1981), but in most of the previous studies the outcome of trabeculec-
tomy between POAG and EG has not signifi cantly differed (Mietz et al. 1999, Popovic & 
Sjöstrand 1999, Serguhn & Spiegel 1999, Edmunds et al. 2001). The proportionate reduc-
tion in IOP can, however, be signifi cantly higher in EG because of initially higher IOP in 
EG (Edmunds et al. 2001). Better control without further therapy in the EG group has also 
been reported (Törnqvist & Drolsum 1991, Konstas et al. 1993), but in these studies, the 
length of use of the preoperative medication in EG was considerably shorter than in our 
series. 
In the present study, the only factors related to losing long-term IOP control in complete-
success cases in multivariate analysis were the presence of EG and an early postoperative 
peak of IOP over 30 mmHg. When complete and qualifi ed success were combined, the dif-
ference between POAG and EG became non-signifi cant, with no independent factors wors-
ening the prognosis. Reasons for the less favourable outcome in EG eyes in this study are 
not clear. In the EG group, the patients were signifi cantly older, the preoperative IOP was 
signifi cantly higher, and postoperative hyphema was signifi cantly more common than in 
the POAG group, but none of these factors proved to be an independent signifi cant predic-
tor of failure in the statistical analysis (proportional hazards regression). In our EG group, 
qualifi ed success and failure eyes had a longer duration of preoperative glaucoma medica-
tion than did eyes with complete success (p=0.06). This may in part explain the results, 
because long-term use of topical antiglaucoma medications have been shown to affect the 
results of trabeculectomy adversely (Sherwood et al. 1989, Lavin et al. 1990).
In this study, early postoperative complications after trabeculectomy were common, but the 
only complication associated with failure was elevated IOP at the end of the fi rst postopera-
tive month resulting from insuffi cient fi ltration. Early hypotony (<5 mmHg lasting 5 days 
or longer), observed in 25% of the eyes, did not predict long-term success or failure, as was 
also reported by Popovic (1995), but which is in contrast with the fi ndings of Migdal and 
Hitchings (1988), who noticed higher fi nal IOP in eyes with low postoperative pressures. 
On the other hand, Schwenn et al. (2001) reported a positive correlation between the lowest 
postoperative pressure and later follow-up pressures. In this series, fi nal success (complete 
or qualifi ed success) did not correlate with lowest postoperative IOP. Reasons for these dif-
ferences are diffi cult to explain. Possibly they refl ect differences in the management of the 
postoperative complications. 
Studies comparing complication rates between POAG and EG are few. Popovic & Sjöstrand 
(1999) found a similar pattern of complications in POAG and EG; specifi c complications 
44 Discussion
were not reported separately. In the present series, postoperative hyphema, found in 17% of 
the eyes, was the only complication that differed signifi cantly between POAG (7%) and EG 
(24%). Törnqvist and Drolsum (1991) reported hyphema rates of 14% in POAG and 19% 
in EG. Increased risk for postoperative hyphema may be explained by the common occur-
rence of vasculopathy in the iris of exfoliative eyes (Vannas 1969, Naumann et al. 1998). 
Concerning the effect of the location of trabeculectomy on IOP and occurrence of compli-
cations, results are somewhat controversial. One might expect that the posterior location 
results in lower IOP due to increased uveal outfl ow or a cyclodialysis type of effect. This 
has not, however, been the case; some studies have shown better results with an anterior 
approach (Watson & Grierson 1981) or have reported no correlation with outcome (Taylor 
1976, Duzanec & Kriegelstein 1981, Konstas & Jay 1992). For the same reason, the risk of 
complications, particularly hypotony (Duzanec & Kriegelstein 1981) and bleeding (Watson 
& Grierson 1981, Konstas & Jay 1992), may be increased by the posterior approach, as was 
also observed in some studies,  but not in others (Taylor 1976). In the present study, loca-
tion of the trephined block in the AC angle did not infl uence the fi nal success rate of IOP 
control or the complication rate signifi cantly, despite a tendency for the posterior location to 
survive better in the EG. In contrast, early hypotony was slightly but not signifi cantly more 
common in the anterior group. In this series, the difference between anterior and posterior 
location observed in histological preparations was probably not marked, because during 
surgery different locations were not the aim. 
Elevated IOP at the end of the fi rst postoperative month resulting from insuffi cient fi ltra-
tion was the only complication associated with failure. This highlights the importance of 
the early postoperative follow-up visits after trabeculectomy and the chance to save some 
of the fi ltering blebs from scarring during the fi rst postoperative month. Proper timing of 
LSL within 7 to 14 days after surgery (Savage et al. 1988, Liebmann & Ritch 1996) and 
recognizing clinical signs possibly associated with poor development of the fi ltering bleb 
and adjusting the postoperative anti-infl ammatory medication in these eyes might enhance 
long-term bleb function (Stewart et al. 1991, Stewart & Pitts 1993, Shingleton 1996, Mar-
quardt et al. 2004). 
6.4 Progression of visual fi eld defects
The present study confi rms earlier fi ndings that VF deterioration may occur over the years 
despite effective IOP-lowering therapy (Kidd & O’Connor 1985, Watson et al. 1990, Roset-
ti et al. 1993, Brubaker 1996). Progression of glaucomatous VF defects occurred in (41%) 
eyes during the follow-up of 2 to 5 years (mean 3.5) after trabeculectomy.
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Most of the fi elds that had progressed were preoperatively classifi ed as severe (20 severe 
vs. 14 mild or moderate). Progression of defects in Goldmann and Octopus fi elds was 
equally common (18/43 vs. 16/40 cases). The fairly high progression rate in this series may 
be explained in part methodologically; the ten patients with early trabeculectomy had only 
one preoperative VF, and in only two-thirds of the cases with VF progression was the deci-
sion concerning defect progression confi rmed by re-examination of VF or by discovery of 
concurrent optic disc changes or loss of fi xation. It is possible that the inter-test variation 
played some role (Heijl et al. 1989, The AGIS Investigators 1994). Misinterpretation of 
the defect progression particularly in cases with severe defects (40% of preoperative VFs), 
of which 61% were examined by Goldmann perimetry, is possible. The progression of VF 
defects by Octopus perimetry was interpreted by the criteria presented by the Glaucoma 
Laser Trial Research Group (1995). For severe defects, these criteria for progression might 
have been too loose.
One explanation for the high progression rate is postoperative IOP level. The initial IOP re-
duction and the absolute IOP reduction from preoperative to last examination was signifi cant-
ly smaller in eyes with VF defect progression. In eyes without progression and in eyes with 
progression, the mean last postoperative IOP did not, however, differ signifi cantly, nor did the 
percentage reduction reach statistical signifi cance, corresponding to the results of Popovic 
& Sjöstrand (1999) in eyes with unchanged/improved vs. deteriorated VF after trabeculec-
tomy. The high standard deviation in mean postoperative IOP in the present study indicates, 
however, that during follow-up, the IOP had been too high in some eyes, particularly in eyes 
that progressed. And it is possible that the single IOP measurements did not discover diurnal 
peaks, although these may be less common following fi ltration surgery than in unoperated 
glaucomatous eyes (Migdal et al. 1986, Wilensky 2004). In newly diagnosed glaucoma with 
mild VF defects, IOP levels 15 to 17 mmHg are probably safe, as shown in the Collaborative 
Initial Glaucoma Treatment Study (CIGTS) (Lichter et al. 2001), but in eyes with advanced 
defects, IOP should be kept as low as the 12 mmHg shown to be safe in associative analysis in 
the Advanced Glaucoma Intervention Study (The AGIS Investigators 2000). VF of eyes even 
with this low pressures have been shown to progress (Kidd & O’Connor 1985), however, as 
was also evident in a few eyes with this pressure level in the present study.
More eyes (65%) with stable VF had a fi nal IOP level of 21 mmHg or lower (complete 
or qualifi ed success) than did those (53%) who progressed, although this difference was 
not statistically signifi cant. In this series we thus could not detect a signifi cant relation-
ship between VF progression and the fi nal IOP level of 21 mmHg or lower. Moreover, the 
number of eyes with an IOP level less than 18 mmHg without any medication or additional 
glaucoma surgery at the fi nal examination was similar in eyes with stable (38%) and with 
progressing VF (32%).
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Signifi cant risk indicators for progressive VF loss in the present series were severe VF 
defect preoperatively, use of preoperative oral antiglaucomatous medications, and smaller 
IOP reduction after surgery, all indicating glaucoma that was more therapy-resistant. The 
disease might have been so far advanced at the time of trabeculectomy that despite IOP 
lowering, VF progression continued after the operation. In some eyes, glaucoma surgery 
may have been used too late. Reasons for postponing glaucoma surgery in elderly patients 
are the risk for possible early complications requiring frequent follow-up visits and possi-
bly additional surgery in the early postoperative period. On the other hand, in patients with 
poor general health, satisfactory IOP control without medication may be the main goal of 
glaucoma surgery because of the side-effects of medications or poor compliance in the use 
of topical glaucoma medication. In contrast with some previous fi ndings, neither older age 
(Stewart et al. 2000, Lichter et al. 2001, Leske et al. 2003, Jonas et al. 2004) nor exfoliation 
(Leske et al. 2003) was a statistically signifi cant risk factor for VF progression, although 
fi eld progression was slightly more common in EG (52%) than in POAG (40%). 
6.5 Visual impairment in operated eyes
Development of glaucoma-related visual impairment and blindness in various studies is 
diffi cult to compare, because the defi nition of blindness varies, stage of VF defects may not 
have been equally severe at the beginning of the follow-up, and some studies do not sepa-
rate glaucoma-related blindness from blindness due to other causes. In this study, during 
the mean follow-up of 3.5 years after trabeculectomy the prevalence of glaucoma-related 
low vision (VA of <0.3 to 0.05) in the operated eye increased from 6% to 7% and that of 
blindness (VA of <0.05 or visual fi eld constriction to <20º at its widest diameter) from 4% 
to 10%. Visual impairment at last follow-up was signifi cantly more common in eyes with 
severe preoperative VF defect, as shown previously (Grant & Burke 1982, Parc et al. 2001, 
Chen 2003), but was not associated with patient age, as proposed by Hattenhauer et al. 
(1998).
The 10% prevalence of glaucoma-related blindness at about 10 years after diagnosis of 
glaucoma in one eye corresponds with fi ndings of Kwon et al. (2001) and Chen (2003), 
although they did not consider various treatment modalities (medication, laser, fi ltration 
surgery) separately, and their defi nition of blindness was less severe (VA ≤20/200 and/or 
VF ≤20º at its widest diameter/in all quadrants). In the present series, at the end of the fol-
low-up period only two patients (1.4%) were blind in both eyes. 
Few studies have examined the probability of becoming blind after fi ltration surgery. Ac-
cording to Molteno et al. (1999), the probability of loss of useful vision (VA ≤20/400 or VF 
≤5º radius) in one eye from any cause was 13%, 28%, and 40% at 5, 10, and 15 years, re-
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spectively, but only one-third was due to progression of glaucoma. Parc et al. (2001) report-
ed higher fi gures, but the criteria were less severe (VA ≤20/200 and/or VF ≤20º in its widest 
diameter); the probability of blindness in one eye in patients with open-angle glaucoma was 
22% at 5 years and 46% at 10 years. In the Advanced Glaucoma Intervention Study (The 
AGIS Investigators 2004), 10-year cumulative incidence of unilateral VA impairment (VA 
<0.2) or VF impairment or both in white patients in a trabeculectomy-ALT-trabeculectomy 
group was 30.4% from all causes.
6.6 Cataract surgery in trabeculectomized eyes
The progression of a cataract is considered to be a late complication of trabeculectomy (The 
AGIS Investigators 2001). Age, EG, diabetes, postoperative hypotony, marked infl amma-
tion, and fl at AC after trabeculectomy have been associated with increased risk for cataract 
(Vesti 1993, The AGIS Investigators 2001). In the present study, patients undergoing cata-
ract surgery during follow-up were signifi cantly older at the time of trabeculectomy than 
were those without cataract surgery, but no other characteristics associated with increased 
risk for cataract emerged. The eyes that underwent cataract surgery had considerably worse 
VA prior to trabeculectomy, supporting the role of age as the most important risk indicator 
for cataract surgery in this series. During follow-up, 26% of POAG and 40% of EG eyes 
had cataract surgery (p=0.09), which corresponds to the 19% of POAG and 32% of EG eyes 
in Popovic & Sjöstrand (1999).
The effect of cataract surgery on IOP or on the number of antiglaucoma medications in 
trabeculectomized eyes is controversial. Some studies show no negative effect (Park et al. 
1997, Manoj et al. 2000, Mietz et al. 2001), while some reveal worsening of IOP control 
or greater number of antiglaucoma medications after phacoemulsifi cation (Chen et al.1998, 
Crichton & Kirker 2001, Halikiopoulos et al. 2001, Casson et al. 2002, Derbolav et al. 
2002, Rebolleda & Muñoz-Negrete 2002, Shingleton et al. 2003). In the present study, 
mean IOP at the last examination was higher, although not signifi cantly so than before 
cataract surgery, but the mean number of topical antiglaucoma medicines had increased 
signifi cantly. In 41% of the eyes, the use of topical antiglaucoma medicines had increased 
after cataract surgery, and four eyes had undergone cyclophotocoagulation. In this series, 
cyclophotocoagulations were done by either a krypton 647 nm or a diode 670 nm laser 
(Raivio 2002). However, in an eye with good IOP control (complete success), a cataract 
operation improved the chances that the eye remained a complete success.
In the present series, prior to cataract surgery, 48% of these eyes were categorized as com-
plete successes, 22% as qualifi ed successes, and 30% as failures. Of those categorized as 
complete successes prior to cataract surgery, 28% remained so during the follow-up. The 
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number of failures increased from 30% before surgery to 61% after cataract surgery. Previ-
ously, continuing good or improved control of IOP without antiglaucoma medication after 
cataract surgery has been reported in 42% (Mietz et al. 2001), with even higher fi gures, up 
to 82%, reported (Crichton & Kirker 2001, Halikiopoulos et al. 2001, Casson et al. 2002, 
Derbolav et al. 2002, Rebolleda & Muñoz-Negrete 2002). In these studies, the high percent-
age of eyes with good postoperative IOP control without medication is in part explained by 
the higher percentages of eyes with good IOP control and functioning fi ltering blebs before 
cataract surgery (up to 100% in Rebolleda & Muñoz-Negrete 2002). The higher fi nal failure 
rate in cataract eyes in this study was in part due to the fact that in 14 eyes cataract surgery 
was performed in eyes in which trabeculectomy had failed to control IOP, and of the 14 new 
failures, 6 had complicated cataract surgery. 
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7. Summary and conclusions
This retrospective study was planned to evaluate the long-term outcome of conventional 
trabeculectomy in POAG and EG. Based on the results of the various substudies, the fol-
lowing conclusions can be drawn.
In this consecutive series of single-surgeon trabeculectomies, females predominated (60%). 
The overall mean age was 70.1 years. The proportion of EG  (60%) was higher than in most 
previous studies, possibly explaining some differences in the outcomes. Preoperative VF 
defect was considered severe in 40%.
Patients with EG were signifi cantly older and had higher preoperative IOP, but the duration 
of their glaucoma was slightly shorter than that of the patients with POAG. 
During the follow-up period, the initially highly signifi cant IOP-reducing effect of trab-
eculectomy gradually decreased, as reported previously. At one year, 82% of the operated 
eyes had an IOP of ≤21 mmHg without or with a single topical medication; at 4 years the 
corresponding percentage was 52%. At the last examination, 53% of eyes were on antiglau-
comatous medication, and 12% had had further glaucoma surgery during follow-up.
Early postoperative complications were common, and hyphema was signifi cantly more 
common in the EG group, but in this series postoperative complications did not predict 
poor outcome. The only signifi cant predictor of failure was an increased IOP at the end of 
the fi rst postoperative month.
The location of the trephined block defi ned in histological preparations as anterior or poste-
rior, did not correlate signifi cantly with long-term success or complication rate.
In this unselected series of eyes, despite trabeculectomy, progression of FV defects was 
fairly common. Progression was associated with severity of initial VF defect. No signifi cant 
correlation appeared between defect progression and the last IOP, but association between 
stability of VF and amount of IOP reduction after surgery, and the high standard deviation 
of the mean postoperative IOP both indicate that a lower target IOP level would be needed, 
particularly in eyes with an initially severe VF defect. However, even eyes with very low 
IOP (< 12 mmHg) did not escape progression of VF defect. 
Development of visual impairment due to glaucoma occurred despite surgery. Glaucoma-
related low vision in the operated eye increased from 6% to 7% and blindness from 4% to 
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10% during the follow-up period, but only 1.4% of the patients became bilaterally blind. 
Development of visual impairment was associated with the severity of initial VF defect. 
In this series, patient age was the only signifi cant risk indicator for cataract surgery. In 
eyes with cataract surgery, the BCVA was already reduced before trabeculectomy, pos-
sibly related to higher age. Patient age thus deserves more blame for cataract progression 
than does trabeculectomy. In an eye with complete success in IOP control, cataract surgery 
improved the chance of that eye’s remaining a complete success through follow-up, but 
one-third (36%) of the eyes categorized as a complete success before cataract surgery were 
considered failures at the last examination. Altogether, the number of failures in the cataract 
surgery group increased from 30% before surgery to 61% at the last examination.
Based on these results, one can emphasize the importance of regular long-term follow-up 
examinations of patients following trabeculectomy. The early postoperative period is cru-
cial to guarantee the development of the fi ltering bleb. It seems that in ordinary clinical set-
tings, an adequate target IOP is not reached in every eye. Earlier surgery might improve the 
results in eyes with EG. In eyes with a fair surgical IOP outcome, more active remedication 
or new surgery should be considered. Regular VF examinations are important also in eyes 
with a good postoperative IOP result. In eyes with good IOP control, cataract surgery may 
not worsen the outcome, but as a whole, cataract surgery after trabeculectomy is likely to 
increase the need for antiglaucomatous medication.
51Acknowledgements
8. Acknowledgements
This study was carried out at the Department of Ophthalmology, Helsinki University Cen-
tral Hospital, from 1997 to 2005.
I am sincerely grateful to Professor Leila Laatikainen, who was the head of the Department 
of Ophthalmology from 1996 to 2003, and who as my supervisor gave me the opportunity 
to perform this work. I have felt privileged, as she has given me her time almost endlessly 
and patiently guided me in clinical research and in writing and editing scientifi c papers. 
Her ambitious and determined attitude in supervising this work was crucial and sets a good 
example for anyone. 
I also wish to express my sincere gratitude to Docent Päivi Puska, my other supervisor, for 
her invaluable knowledge of glaucoma and her constructive criticism.
My warmest appreciation goes to Ilkka Lehto, MD, PhD, for performing the trabeculecto-
mies and for his encouragement in writing up the results.
I also appreciate the work of the cataract surgeons who performed the cataract surgeries in 
these patients.  
My deepest appreciation goes to Professors Esko Aine and Jost Jonas for their critical and 
constructive revision of the manuscript.
I also appreciate Professor Tero Kivelä, the present head of the Department of Ophthalmol-
ogy, for his wise guidance and admirable enthusiasm in clinical ophthalmology during my 
residency, Docent Lauri Merenmies for having examined the trephined tissue blocks at the 
pathology laboratory of the Helsinki University Eye Hospital, and all the private practition-
ers who have helped me gather the follow-up data.
I also thank for their friendly support and collaboration the personnel of the glaucoma de-
partment.
I thank my colleagues and friends, especially Liisa Lähteenoja, Helena Pelkonen, Virpi 
Raivio, Mika Harju, and Minna Vesaluoma, for creating an inspiring atmosphere at the 
clinic with their interest in ophthalmology and research. I especially thank Virpi Raivio for 
her support at the Nordic Congress of Ophthalmology (XXXIV Nordiska Ögonläkarmötet) 
in June 2000, Reykjavik, Iceland, during my second pregnancy.
52 Acknowledgements
I thank Mrs Jean Margaret Perttunen (fi rst and second article) and Carol Norris, PhD, who 
revised the English language of this thesis, and Timo Pessi, MSc, for consultation on sta-
tistical analysis.
I am grateful to Teo Hämäläinen, research technician, for his help with the computers.
I also wish to express my gratitude to my husband Alexander for his support with the com-
puters and for sharing most of my good fortune and my misfortune during this work, and 
for providing recreation in Pernaja in the countryside.
Heartfelt thanks are owned to our sons Philip (12) and Arthur (4) for sharing a part of their 
everyday life with this thesis. 
Financial support for this study was provided by grants from the Mary and Georg C. 
Ehrnrooth Foundation, the Eye and Tissue Bank Foundation (Silmä- ja kudospankkisäätiö), 
the Eye Foundation (Silmäsäätiö), and the Glaucoma Foundation LUX (Glaukooma tuki-
säätiö LUX), Finland.
   Helsinki, December 2005
   Pia Ehrnrooth
53References
9. References
The AGIS Investigators. Advanced Glaucoma Intervention Study 2. Visual fi eld test scor-
ing and reliability. Ophthalmology 1994;101:1445–1455.
The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The re-
lationship between control of intraocular pressure and visual fi eld deterioration. Am J 
Ophthalmol 2000;130:429–440.
The AGIS Investigators. The Advanced Glaucoma Intervention Study, 8: Risk of cataract 
formation after trabeculectomy. Arch Ophthalmol 2001;119:1771–1780.
The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk 
factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthal-
mol 2002;134:481–498.
The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Base-
line risk factors for sustained loss of visual fi eld and visual acuity in patients with 
advanced glaucoma. Am J Ophthalmol 2002;134:499–512.
The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 13. Compari-
son of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651–
664.
Akafo SK, Goulstine DB, Rosenhal AR. Long-term post trabeculectomy intraocular pres-
sures. Acta Ophthalmol 1992;70:312–316.
Ambresin A, Shaarawy T, Mermoud A. Deep sclerectomy with collagen implant in one 
eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma 
2002;11:214–220.
Araujo SV, Spaeth GL, Roth SM, Starita RJ. A ten-year follow-up on a prospective, ran-
domized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology 
1995;102:1753–1759.
Asamoto A, Yablonski ME, Matsushita M. A retrospective study of the effects of laser suture 
lysis on the long-term results of trabeculectomy. Ophthalmic Surg 1995;26:223–227.
Aulhorn E. Sensoric functional damage. In: Heilmann K, Richardson KT, eds. Glaucoma-
conceptions of a disease. Stuttgart: Georg Thieme Verlag, 1978;157–180. 
Batterbury M, Wishart PK. Is high initial aqueous outfl ow of benefi t in trabeculectomy? 
Eye 1993;7:109–112.
54 References
Bindlish R, Condon GP, Schlosser JD, D’Antonio J, Lauer KB, Lehrer R. Effi cacy and safe-
ty of Mitomycin-C in primary trabeculectomy. Ophthalmology 2002;109:1336–1342.
Borisuth NSC, Phillips B, Krupin T. The risk profi le of glaucoma fi ltration surgery. Curr 
Opin Ophthalmol 1999;10:112–116.
Briggs MC, Jay JL. Age over 46 years does not affect the pressure lowering effect of trab-
eculectomy in primary open angle glaucoma. Br J Ophthalmol 1999;83:280–284.
Broadway DC, Grierson I, O’Brien C, Hitchings RA. Adverse effects of topical antiglaucoma 
medication: II. The outcome of fi ltration surgery. Arch Ophthalmol. 1994;112:1446–
1454. 
Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative 
state of conjunctiva. J Glaucoma 2001;10:237–249.
Brubaker RF. Delayed functional loss in glaucoma. Am J Ophthalmol 1996;121:473–483.
Cairns JE. Trabeculectomy: preliminary report of a new method. Am J Ophthalmol 
1968;66:673–679.
Cairns JE. Surgical treatment of primary open-angle glaucoma. Trans Ophth Soc U.K. 
1972;92:745–756.
Carassa RG, Bettin P, Fiori M, Brancato R. Viscocanalostomy versus trabeculectomy in 
white adults affected by open-angle glaucoma. Ophthalmology 2003;110:882–887.
Casson R, Rahman R, Salmon JF. Phacoemulsifi cation with intraocular lens implantation 
after trabeculectomy. J Glaucoma 2002;11:429–433.
Chauhan BC, Drance SM. The relationship between intraocular pressure and visual fi eld 
progression in glaucoma. Graefes Arch Clin Exp Ophthalmol 1992;230:521–526.
Chen TC, Wilensky JT, Viana MAG. Long-term follow-up of initially successfull trab-
eculectomy. Ophthalmology 1997;104:1120–1125.
Chen PP, Weaver YK, Budenz DL, Feuer WJ, Parrish RK. Trabeculectomy function after 
cataract extraction. Ophthalmology 1998;105:1928–1935.
Chen PP. Blindness in patients with treated open-angle glaucoma. Ophthalmology 2003;110: 
726–733.
Costa VP, Smith M, Spaeth GL, Gandham S, Markovitz B. Loss of visual acuity after trab-
eculectomy. Ophthalmology 1993;100:599–612.
55References
Costa VP, Correa MM, Kara-Jose N. Needling versus medical treatment in encapsulated 
blebs. Ophthalmology 1997;104:1215–1220.
Crichton ACS, Kirker AW. Intraocular pressure and medication control after clear corneal 
phacoemulsifi cation and AcrySof posterior chamber intraocular lens implantation in 
patients with fi ltering blebs. J Glaucoma 2001;10:38–46.
Derbolav A, Vass C, Menapace R, Schmetterer K, Wedrich A. Long-term effect of phacoe-
mulsifi cation on intraocular pressure after trabeculectomy. J Cataract Refract Surg 
2002;28:425–430.
D‘Ermo F, Bonomi L , Doro D. A critical analysis of the long-term results of trabeculec-
tomy. Am J Ophthalmol 1979;88:829–835.
Diestelhorst M, Khalili MA, Krieglstein GK. Trabeculectomy: a retrospective follow-up of 
700 eyes. International Ophthalmology 1999;22:211–220.
Downes SM, Misson GP, Jones HS, O’Neill EC. The predictive value of post-operative 
intraocular pressures following trabeculectomy. Eye 1994;8:394–397.
Duzanec Z, Kriegelstein GK. Die Beziehung zwischen Druckregulierung und anatomischer 
Lokalisation sowie Trepangröße bei der Goniotrepanation. Klin Mbl Augenheilk 1981; 
178:431–435.
Edmunds B, Thompson JR, Salmon JF, Wormald RP. The national survey of trabeculec-
tomy. II. Variations in operative technique and outcome. Eye 2001;15:441–448.
The Fluorouracil Filtering Surgery Study Group. Fluorouracil fi ltering surgery study one-
year follow-up. Am J Ophthalmol 1989;108:625–635.
The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the fl uorouracil 
fi ltering surgery study. Am J Ophthalmol 1996;121:349–66.
Fronimopoulos J, Lambrou N, Pelekis N, Christakis Ch. Elliotsche trepanation mit skleral-
deckel. Monatsblätter für Augenheilkunde 1970;156:1–8.
Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT): 6. Treatment 
group differences in visual fi eld changes. Am J Ophthalmol 1995;120:10–22.
Grant WM, Burke JF Jr. Why do some people go blind from glaucoma? Ophthalmology 
1982;89:991–998.
Halikiopoulos D, Moster MR, Azuara-Blanco A, Wilson RP, Schmidt CM, Spaeth GL, Katz 
LJ, Augsburger JJ. The outcome of the functioning fi lter after subsequent cataract ex-
traction. Ophthalmic Surg Lasers 2001;32:108–117.
56 References
Hart WM Jr, Becker B. The onset and evolution of glaucomatous visual fi eld defects. Oph-
thalmology 1982;89:268–279.
Hattenhauer MG, Johnson DH, Ing HH, Herman DC, Hodge DO, Yawn BP, Butterfi eld LC, 
Gray DT. The probability of blindness from open-angle glaucoma. Ophthalmology 
1998;105: 2099–2104.
Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fi elds. Am 
J Ophthalmol 1989;108:130–135.
Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, and the EMGT 
group. Reduction of intraocular pressure and glaucoma progression. Results from the 
Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268–1279.
Hirvelä H, Tuulonen A, Laatikainen L. Intraocular pressure and prevalence of glaucoma 
in elderly people in Finland: a population-based study. International Ophthalmology 
1995;18:299–307.
Hoskins HD Jr, Migliazzo C. Management of failing fi ltering blebs with the argon laser. 
Ophthalmic Surg 1984;15:731–733.
Jacobi PC, Dietlein TS , Krieglstein GK. Primary trabeculectomy in young adults: Long-
term clinical results and factors infl uencing the outcome. Ophthalmic Surg Lasers 
1999;30:637–646.
Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE, the collabo-
rative initial glaucoma treatment study group. Perioperative complications of trab-
eculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J 
Ophthalmol 2005;140:16–22.
Jay JL, Murray SB. Early trabeculectomy versus conventional management in primary 
open angle glaucoma. Br J Ophthalmol 1988;72:881–889.
Jay JL, Allan D. The benefi t of early trabeculectomy versus conventional management in 
primary open angle glaucoma relative to severity of disease. Eye 1989;3:528–535.
Jerndal T , Lundström M. 330 Trabeculectomies: A follow-up study through ½–3 years. 
Acta Ophthalmol (Copenh) 1977;55:52–62.  
Jerndal T , Lundström M. 330 Trabeculectomies: A long time study (3–5½ years). Acta 
Ophthalmol 1980;58:947–956.
Jonas JB, Martus P, Horn FK, Junemann A, Korth M, Budde WM. Predictive factors of the 
optic nerve head for development or progression of glaucomatous visual fi eld loss. 
Invest Ophthalmol Vis Sci 2004;45(8):2613–8.
57References
Katz J, Congdon N, Friedman DS. Methodological variations in estimating apparent pro-
gressive visual fi eld loss in clinical trials of glaucoma treatment. Arch Ophthalmol 
1999;117:1137–1142.
Kidd MN, O’Connor M. Progression of fi eld loss after trabeculectomy: a fi ve-year follow-
up. Br J Ophthtalmol 1985;69:827–831.
Kimbrough RL, Stewart RH, Decker WL, Praeger TC. Trabeculectomy: Square or triangu-
lar scleral fl ap? Ophthalmic Surg 1982;13:753.
Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin. A 
comparative study with fl uorouracil. Arch ophthalmol 1991;109:1693–1698.
Kolker AE, Kass MA, Rait JL. Trabeculectomy with releasable sutures. Trans Am Ophthal-
mol Soc 1993;91:131–141.
Konstas APG, Jay JL. Modifi cation of trabeculectomy to avoid postoperative hyphaema. 
The ‘guarded anterior fi stula’ operation. Br J Ophthalmol 1992;76:353–357.
Konstas AGP, Jay JL, Marshall GE, Lee WR. Prevalence, diagnostic features, and response 
to trabeculectomy in exfoliation glaucoma. Ophthalmology 1993;100:619–627.
Krause U. Frequency of capsular glaucoma in central Finland. Acta Ophthalmol (Copenh) 
1973;51:235–240.
Kwon YH, Kim C-S, Zimmerman B, Alward WLM, Hayreh SS. Rate of visual fi eld loss 
and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol 
2001;132:47–56.
Lamping KA, Bellows AR, Hutchinson BT, Afran SI. Long-term evaluation of initial fi ltra-
tion surgery. Ophthalmology 1986;93:91–101.
Lavin MJ, Wormald RPL, Migdal CS, Hitchings RA. The infl uence of prior therapy on the 
success of trabeculectomy. Arch Ophthalmol 1990;108:1543–1548.
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma 
progression and the effect of treatment. The Early Manifest Glaucoma Trial. Arch 
Ophthalmol 2003;121:48–56.
Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP, the CIGTS 
Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treat-
ment Study comparing initial treatment randomized to medications or surgery. Oph-
thalmology 2001;108:1943–1953.
58 References
Liebmann JM, Ritch R. Complications of glaucoma fi ltering surgery. In: Ritch R, Shields 
MB, Krupin T. The glaucomas. St. Louis, Missouri: Mosby-Year Book, 1996;1710.
Liesegang TJ. Conjunctival changes associated with glaucoma therapy: implications for the 
external disease consultant and the treatment of glaucoma. Cornea 1998;17(6):574–
583.
Lindberg JG. Kliniska undersökningar över depigmenteringen av pupillarranden och ge-
nomlysbarheten av iris vid fall av åldersstarr samt i normala ögon hos gamla personer. 
Dissertation. Helsinki. 1917. 
Lüke C, Dietlein TS, Jacobi PC, Konen W, Kriegelstein GK. A prospective randomized trial 
of viscocanalostomy versus trabeculectomy in open-angle glaucoma: a 1-year follow-
up study. J Glaucoma 2002;11:294–299.
Macken P, Buys Y, Trope GE. Glaucoma laser suture lysis. Br J Ophthalmol 1996;80:398-
401.
Manoj B, Chako D, Khan MY. Effect of extracapsular cataract extraction and phacoemul-
sifi cation performed after trabeculectomy on intraocular pressure. J Cataract Refract 
Surg 2000;26:75–78.
Mao LK, Stewart WC, Schields MB. Correlation between intraocular pressure control and 
progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthal-
mol 1991; 111:51–55.
Marquardt D, Lieb WE, Grehn F. Intensifi ed postoperative care versus conventional fol-
low-up: a retrospective long-term analysis of 177 trabeculectomies. Graefe’s Arch 
Clin Exp Ophthalmol 2004;242:106–113.
Martínez-Belló C, Chauhan BC, Nicolela MT, McCormic TA, LeBlanc RP. Intraocu-
lar pressure and progression of glaucomatous visual fi eld loss. Am J Ophthalmol 
2000;129:302–308.
Mietz H, Raschka B, Kriegelstein GK. Risk factors for failures of trabeculectomies per-
formed without antimetabolites. Br J Ophthalmol 1999;83:814–821.
Mietz H, Andresen A, Welsandt, Kriegelstein GK. Effect of cataract surgery on intraocular 
pressure in eyes with previous trabeculectomy. Graefe’s Arch Clin Exp Ophthalmol 
2001;239:763–769.
Migdal C, Hitchings R. Control of chronic simple glaucoma with primary medical, surgical 
and laser treatment. Trans. Ophthalmol. Soc. U.K. 1986;105:653–656.
59References
Migdal C, Hitchings R. Morbidity following prolonged postoperative hypotony after 
trabeculectomy. Ophthalmic Surg 1988;19:865–867.
Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early sur-
gery compared with laser and medicine in open-angle glaucoma. Ophthalmology 
1994;101:1651–1657.
Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas 
in glaucoma. Am J Ophthalmol 1986;101:1–6.
Miller KN, Blasini M, Shields MB, Ho C-H. A comparison of total and partial tenon-
ectomy with trabeculectomy. Am J Ophthalmol 1991;111:323–326.
Mills KB. Trabeculectomy: a retrospective long term follow-up of 444 cases. Br J 
Ophthalmol 1981;65:790–795.
Molteno ACB, Bosma NJ, Kittelson JM. Otago Glacoma Surgery Outcome 
Study. Long-term results of trabeculectomy – 1976 to 1995. Ophthalmology 
1999;106:1742–1750.
Naumann GOH, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliation Syndrome for 
the Comprehensive Ophthalmologist. Ophthalmology 1998;105:951–968.
Nouri-Mahdavi K, Brigatti L, Weitzman M , Caprioli J. Outcomes of trabeculectomy 
for primary open-angle glaucoma. Ophthalmology 1995;102:1760−1769.
Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, Caprioli 
J. Predictive factors for glaucomatous visual fi eld progression in the advanced 
glaucoma intervention study. Ophthalmology 2004;111:1627–1635.
O´Brien C, Schwartz B, Takamoto T, Wu DC. Intraocular pressure and the rate of vis-
ual fi eld loss in chronic open-angle glaucoma. Am J Ophthalmol 1991;111:491–
500.
Ojamo M. The Finnish Register of Visual Impairment. Annual Statistics 2002. Na-
tional Research and Development Centre for Welfare and Health in Finland. Hel-
sinki: Vientipaino Oy, 2003;22.
Palmberg P. How clinical trial results are changing our thinking about target pres-
sures. Current Opinion in Ophthalmology 2002;13:85–88.
Parc CE, Johnson DH, Oliver JE, Hattenhauer MG, Hodge DO. The long-term out-
come of glaucoma fi ltration surgery. Am J Ophthalmol 2001;132:27–35. 
Park HJ, Kwon YH, Weitzman M, Caprioli J. Temporal corneal phacoemulsifi cation 
in patients with fi ltered glaucoma. Arch Ophthalmol 1997;115:1375–1380.
60 References
Peräsalo R, Raitta C. The prevalence and type of glaucoma in geriatric patients. Acta Oph-
thalmol 1992;70:308–311.
Peräsalo R. Phaco-emulsifi cation of cataract in eyes with glaucoma. Acta Ophthalmol 
Scand 1997;75:299–300.
Picht G, Mutsch Y, Grehn F. Nachbetreuung von Trabekulektomien. Komplikationen und 
therapeutische Konsequenzen. Ophthalmologe 2001;98:629–643.
Pohjalainen T. Effect of cataract surgery on visual outcome, intraocular pressure and pos-
terior capsular opacifi cation in normal and glaucomatous eyes. Academic dissertation. 
Helsinki: Yliopistopaino, 2001.
Pohjalainen T, Vesti E, Uusitalo R, Laatikainen L. Phacoemulsifi cation and intraocular lens 
implantation in eyes with open-angle glaucoma. Acta Ophthalmol Scand 2001;79:313–
316.
Popovic V, Sjöstrand J. Long-term outcome following trabeculectomy: I. Retrospective 
analysis of intraocular pressure regulation and cataract formation. Acta Ophthalmol 
1991;69:299–304.
Popovic V, Sjöstrand J. Long-term outcome following trabeculectomy: II. Visual fi eld sur-
vival. Acta Ophthalmol 1991;69:305–309.
Popovic V. Early hypotony after trabeculectomy. Acta Ophthalmol Scand 1995;73:255–
260.
Popovic V, Sjöstrand J. Course of exfoliation and simplex glaucoma after primary trab-
eculectomy. Br J Ophthalmol 1999;83:305–310. 
Puska P, Tarkkanen A. Exfoliation syndrome as a risk factor for cataract development: 
fi ve-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg 
2001;27:1992–1998.
Raina UK, Tuli D. Trabeculectomy with releasable sutures: a prospective, randomized pilot 
study. Arch Ophthalmol 1998;116:1288–1293.
Raivio VE. Transscleral red laser cyclophotocoagulation for treatment of therapy-resistant 
glaucoma. Academic dissertation. Helsinki: Yliopistopaino, 2002.
Rasker MTE, van den Enden A, Bakker D, Hoyng PFJ. Rate of visual fi led loss in progres-
sive glaucoma. Arch Ophthalmol 2000;118:481–488.
Rebolleda G, Muñoz-Negrete FJ. Phacoemulsifi cation in eyes with functioning fi ltering 
blebs: A prospective study. Ophthalmology 2002;109:2248–2255.
61References
Rossetti L, Marchetti I, Orzalesi N, Scorpiglione N, Torri V , Liberati A. Randomized 
clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical 
practice? Arch Ophthalmol 1993;111:96–103.
Roth SM, Spaeth GL, Starita RJ, Birbillis EM, Steinmann WC. The effects of postopera-
tive corticosteroids on trabeculectomy and the clinical course of glaucoma: fi ve-year 
follow-up study. Ophthalmic Surgery 1991;22:724–729.
Salim S, Paranhos A, Lima M, Shields MB. Infl uence of surgical reduction of intraocular 
pressure on regions of the visual fi eld with different levels of sensitivity. Am J Oph-
thalmol 2001;132:496–500.
Sanders R, MacEwen CJ, Haining WM. Trabeculectomy: effect of varying surgical site. 
Eye 1993;7:440–443.
Savage JA, Simmons RJ. Staged glaucoma fi ltration surgery with planned early conversion 
from scleral fl ap to full-thickness operation using argon laser. Ophthalmic Laser Ther 
1986;1:201–210.
Savage JA, Condon GP, Lytle RA, Simmons RJ. Laser suture lysis after trabeculectomy. 
Ophthalmology 1988;95:1631–1638.
Schwartz AL, Van Veldhuisen PC, Gaasterland DE, Ederer Fred, Sullivan EK, Cyrlin MN. 
The advanced glaucoma intervention study (AGIS): 5. Encapsulated bleb after initial 
trabeculectomy. Am J Ophthalmol 1999;127:8–19.
Schwenn O, Kersten I, Dick HB, Müller H, Pfeiffer N. Effects of early postfi ltration ocular 
hypotony on visual acuity, long-term intraocular pressure control, and posterior seg-
ment morphology. J Glaucoma 2001;10:85–88.
Serguhn S , Spiegel D. Vergleich des postoperativen Verlaufes nach Trabekulektomie bei 
Pseudoexfoliationsglaukom und primärem chronischen Offenwinkelglaukom. Klin 
Monatsb Augenheilkd 1999;215:281–286. 
Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of 
antiglaucoma drugs on the conjunctiva and tenon’s capsule in glaucomatous patients. 
Ophthalmology 1989;96:327–335.
Shingleton BJ. Management of the failing glaucoma fi lter. Ophthalmic Surgery and Lasers 
1996;27:445–451.
Shingleton BJ, O’Donoghue MW, Hall PE. Results of phacoemulsifi cation in eyes with 
preexisting glaucoma fi lters. J Cataract Refract Surg 2003;29:1093–1096.
62 References
Shuster JN, Krupin T, Kolker AE, Becker B. Limbus- v fornix-based conjunctival fl ap in 
trabeculectomy: a long-term randomised study. Arch Ophthalmol 1984;102:361–362.
Singh K, Spaeth G, Zimmerman T, Minckler D. Target pressure-glaucomatologists’ holey 
grail. Ophthalmology 2000;107:629–630.
Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fi elds 
in glaucoma. Invest Ophthalmol Vis Sci 1996;37:1419–1428.
Starita RJ, Fellman RL, Spaeth GL, Poryzees EM. Effect of varying size of scleral fl ap and 
corneal block on trabeculectomy. Ophthalmic Surg 1984;15:484–487. 
Stewart WC, Shields MB, Miller KN, Blasini M, Sutherland SE. Early postoperative prog-
nostic indicators following trabeculectomy. Ophthalmic Surgery 1991;22:23–26.
Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in 
patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthal-
mol 1993;116:176–181.
Stewart WC, Pitts RA. Postoperative prognostic indicators following trabeculectomy. Acta 
Ophthalmologica 1993;71:733–738.
Stewart WC, Sine CS, LoPresto C. Surgical vs medical management of chronic open-angle 
glaucoma. Am J Ophthalmol 1996;122:767–774.
Stewart WC, Kolker AE, Sharpe ED, Day DG, Holmes KT, Leech JN, Johnson M, Cantrell 
J B. Factors associated with long-term progression or stability in primary open-angle 
glaucoma. Am J Ophthalmol 2000;130:274–279.
Sugar SH. Experimental trabeculectomy in glaucoma. Am J Ophthalmol 1961;51:623–
627.
Sugar HS. Postoperative cataract in successfully fi ltering glaucomatous eyes. Am J Oph-
thalmol 1970;69:740–746.
Suzuki Y, Shirato S, Adachi M, Hamada C. Risk factors for the progression of treated pri-
mary open-angle glaucoma: a multivariate life-table analysis. Graefe’s Arch Clin Exp 
Ophthalmol 1999;237:463–467.
Tarkkanen A. Pseudoexfoliation of the lens capsule. Open-angle glaucoma. Acta Ophthal-
mol (Copenh) 1962; Suppl. 71.
Taylor HR. A histologic survey of trabeculectomy. Am J Ophthalmol 1976;82:733–735.
63References
Tezel G, Siegmund KD, Trinkaus K, Wax MB, Kass Ma, Kolker AE. Clinical factors as-
sociated with progression of glaucomatous optic disc damage in treated patients. Arch 
Ophthalmol 2001;119:813–818.
Traverso CE, Tomey KF, Antonios S. Limbal- vs fornix-based conjunctival trabeculectomy 
fl aps. Am J Ophthalmol 1987;104:28–32.
Tuulonen A, Airaksinen PJ, Erola E, Forsman E, Friberg K, Kaila M, Klemetti A, Mäkelä 
M, Oskala P, Puska P, Suoranta L, Teir H, Uusitalo H, Vainio-Jylhä E, Vuori M-L. The 
Finnish evidence-based guideline for open-angle glaucoma. Acta Ophthalmol. Scand. 
2003;81:3–18.
Törnqvist G , Drolsum LK. Trabeculectomies. A long term study. Acta Ophthalmol 1991; 
69:450–454.
Vannas A. Fluorescein angiography of the vessels of the iris in pseudoexfoliation of the 
lens capsule, capsular glaucoma and some other forms of glaucoma. Acta Ophthalmol, 
Suppl 1969;105.
Vesti E, Raitta C. Trabeculectomy at the inferior limbus. Acta Ophthalmol 1992;70:220–
224.
Vesti E. Filtering Blebs: Follow up of trabeculectomy. Ophthalmic Surgery 1993;24:249–
255. 
Vesti E. Development of cataract after trabeculectomy. Acta Ophthalmol (Kbh) 1993;71:777–
781.
Vesti E, Raitta C. A review of the outcome of trabeculectomy in open-angle glaucoma. 
Ophthalmic Surg Lasers 1997;28:128–132.
Vogel R, Crick RP, Newson RB, Shipley M, Blackmore H, Bulpitt CJ. Association between 
intraocular pressure and loss of visual fi eld in chronic simple glaucoma. Br J Ophthal-
mol 1990;74:3–6.
Vuori M-L, Viitanen T. ”Scleral tunnel incision”-trabeculectomy with one releasable su-
ture. Acta Ophthalmol Scand 2001;79:301–304.
Watson PG. Trabeculectomy: a modifi ed ab externo technique. Ann Ophthalmol 1970;2:199–
205.
Watson PG , Grierson I. The place of trabeculectomy in the  treatment of  glaucoma. Oph-
thalmology 1981;88:175–196.
64 References
Watson PG, Jakeman C, Ozturk M, Barnett MF, Barnett F, Khaw KT. The complications of 
trabeculectomy (a 20-year follow-up). Eye 1990;4:425–438.
 Werner EB, Bishop KI, Koelle J, Douglas GR, LeBlanc RP, Mills RP, Schwartz B, Whalen 
WR, Wilensky JT. A comparison of experienced clinical observers and statistical tests 
in detection of progressive visual fi eld loss in glaucoma using automated perimetry. 
Arch Ophthalmol 1988;106:619–623. 
Wilensky JT. The role of diurnal pressure measurements in the management of open angle 
glaucoma. Current Opinion in Ophthalmology 2004;15:90–92.
Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed glaucoma valve implant vs trab-
eculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J 
Ophthalmol 2000;130:267–273.
World Health Organization. International classifi cation of impairments, disabilities and 
handicaps. A manual of classifi cation. Geneva: World Health Organization, 1980. 
